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ABSTRACT 
 There have been multiple studies of how monetary compensation affects perceived 
willingness to participate in medical research. However few studies have addressed 
perception of risk, especially risk to privacy associated with genetic or behavioral genetic 
investigations. One recent study, an M.S. thesis investigation by Ascheman (2009), identified 
several difficulties in studying undergraduate perceptions of risk from participation in such 
investigations: low levels of comprehension of informed consent documents, and difficulties 
in separating participants’ perceptions of risk to privacy from the potential influences of 
money offered for participation. This study expands the work of Ascheman (2009) by using a 
vignette story format for presentation of the experimenter-constructed informed consents. It 
also included a baseline privacy risk without compensation condition in a 2 (level of privacy 
risk) X 2 (level of compensation) mixed within-between subjects design. The study was 
conducted as an online investigation with undergraduate research volunteers. The presented 
levels of risk had a significant effect on participants' willingness to participate and perception 
of risk at all presented levels of risk and compensation. However, no significant risk-by 
compensation interactions were found. Moreover, the compensation offered (ten versus one 
hundred dollars) in the vignettes did not have a significant differential effect on either 
willingness to participate or perception of risk at any of the presented levels of risk. 
Additionally, monetary compensation did not demonstrate a main effect on either of these 
measures with the exception of a willingness to participate variable that asked how 
participants believed others would react to the presented vignettes. Compared with prior 
studies, the use of a short vignette in a story-format informed consent, substantially increased 
comprehension of the essential experimenter constructed informed consent information about 
ix 
 
risk to privacy and monetary compensation. Comprehension checks demonstrated between 
62.4% and 84.2% accurate comprehension of essential risk or money information from the 
experimenter constructed informed consents at various levels of risk and money. 
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CHAPTER 1 
INTRODUCTION 
 The use of genetic analysis is rapidly increasing in a variety of research fields. Moreover, 
as insight has been gained into how genetics affects personality and dysfunctional behaviors, 
there has been an increase in behavioral genetic research in psychology (Leonardo & Hen, 2006). 
There is research relating to the potential ethical concerns unique to genetic research, (Burgess, 
Laberge, & Knoppers, 1998, Pelletier & Dorval, 2004) however the implications of obtaining 
genetic information may frequently extend beyond a given individual’s unique genetic code 
(Burgess, Laberge, & Knoppers, 1998). Thus, the unique, enduring, and personally identifying 
nature of DNA may make the loss, or potential loss of an individual’s genetic information, their 
genetic privacy, potentially severe. The field of bioethics has seen several major shifts in the past 
several decades, from a ‘doctor knows best’ model of frequently uninformed consent to the 
current central focus on autonomy of the individual for their own care and information. The idea 
that genetic information about one individual and their testing or treatment may profoundly 
affect another individual or even an entire family or ethnic group is still a relatively new concept 
within bioethics (Green, 1999). 
  Many areas of science are undergoing significant transformations based on genetic 
research.  Some groups have now renewed the specter of the eugenics movement of the early 20
th
 
century around the advent of new genetic screening techniques and emerging genetic research 
(Petersen, 1999).  The eugenics movement  is predicated on the Darwinian idea of selecting  and 
ultimately creating of individuals  with the best possible genetic make-up  and thus limiting the 
number ‘bad’ or ‘unhealthy’ genes being introduced or passed down.  While many gay rights 
groups have heralded research on the so-called ‘gay gene’ that attempts to demonstrate that 
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sexual orientation is an inherently biological factor, many other groups in the same vein argue 
that the ability to genetically screen for this gene, for example by expectant parents, could 
potentially allow parents to decide what sexual orientation their children have and eliminate the 
LGBT community entirely (Green, 1999).  
Also in the realm of criminal justice, forensic genetic profiling has become much more 
commonplace, with scientists now able to uniquely identify an individual based on 13 highly 
variable parts of the human genome unless that individual has a twin.  All fifty states also now 
contribute genetic sample data to the Combined DNA Index System (CODIS), with more than 
half of states taking genetic samples from all felons and over 20 states collecting samples from 
anyone convicted of a misdemeanor (Ossorio & Duster, 2005).  While helpful for proving the 
innocence of wrongly-convicted persons, this practice raises concerns around the frequently 
demonstrated higher rates of racial minority convictions and the subsequent research that is 
taking place on these databases for behavioral ‘explanations’ of criminal activity (Ossorio & 
Duster, 2005).  These kinds of ethical concerns are unique to behavioral genetic research, but 
very little attention has been paid to how aware are research participants to these potential risks, 
and wider implications of their participation, or how informed and accurate are their perceptions 
of informed consent for research participation. 
Participants’ Risk Perceptions, Monetary Compensation, and involvement in Research 
Several studies have attempted to assess how level of risk and variations in monetary 
compensation affect individuals’ willingness to participate in medical research (Halpern et al. 
2004, Bentley & Thacker, 2004).  While the literature appears mixed on how monetary 
compensation affects willingness to participate, one consistent finding is that increased risk does 
indeed lead to decreased willingness to participate in these studies.  For example, in a seminal 
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article pertinent to online research studies, Couper, Singer, Conrad & Groves  (2008) conducted 
a series of large sample (3672 participants) web-based vignette experiments investigating how 
likely subjects would be to participate in surveys varying in topic sensitivity and risk of 
disclosure.  It was found that objective risk did not have an effect on willingness to participate. 
However, topic sensitivity and general attitudes toward privacy, as well as subjective perceptions 
of risk, harm and benefit did have effects.   However, much of the existing research that jointly 
examines risk and monetary compensation on persons’ willingness to participate in research 
focuses specifically on medical studies such as drug trials. Many of these studies do not address 
the unique concerns pertinent to behavioral genetic research, the substantial risk to privacy and 
long-range welfare from the misuse of specific person identifying DNA.  
Ascheman (2009) did address some of the perceived privacy risks in behavioral genetic 
research by examining how online research participants perceived, comprehended and acted 
upon informed consent documents involving potential loss of genetic privacy.  A major difficulty 
encountered in his study was participants’ extremely low levels of comprehension of a written 
informed consent. Only 14% of participants demonstrated an understanding of the potential risks 
(will my DNA sample have my name attached to it?)  as well as amount of compensation (how 
much will I be paid for my participation?) as assessed by a comprehension check after a reading 
a hypothetical experimenter-constructed  informed consent and by use the joint most stringent 
comprehension criterion.  
In the Ascheman study the informed consent documents were the experimental 
manipulations, with four different combination of either high or low monetary compensation 
combined with ether high or low risk to loss to genetic privacy. However, with the assessed low 
rate of comprehension of the consent information, only a segment of the total participants (14%) 
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could be considered to be sufficiently “informed” to justify their inclusion in the data analyses. 
Thus, the generalizability of findings was compromised. Recent research (Pedersen, Neighbors, 
Tidwell & Lostutter, 2011) which focused on undergraduate student research participants’ 
reading comprehension and memory (recognition and recall) for information in consent forms 
also indicated limited comprehension and poor recall. In a study of two hundred and sixty 
undergraduate research participants at a research- focused university, it was found that the 
majority of them (between 69% and 80% across all conditions) were unable to recall information 
from the consent forms when presented in either in-person or online formats.  They were also 
relatively poor at recognizing important aspects of the form including risk to participants and 
confidentiality procedures. 
This study was designed to expand the findings of Ascheman (2009) by using a series of 
new methods aimed at improving participant comprehension and more clearly separating the 
potential effects of the variables of monetary compensation and perception of risk by creating an 
additional no-compensation condition in order to establish a baseline of risk perception.  Further, 
this study has attempted to gain additional insight into how levels of monetary compensation 
influence perception of risk in genetic studies through a mixed design that allowed all 
participants to react to both high and low levels of risk but with the amount of compensation 
being offered held constant for each participant. 
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CHAPTER 2 
LITERATURE REVIEW 
 The basic principles underlying modern ethical principles that currently govern genetic 
and other biomedical research fields have developed over human history, beginning in ancient 
Greece and Rome.  However, even with such a long history underpinning it, researching 
informed consent for biomedical research is complex (Corrigan, 2003).  The purpose of this 
literature review is to provide an examination of the relevant history and current state of ethical 
principles, and additionally to provide a brief overview of the current biomedical and genetic-
medical ethical concerns. 
History of Biomedical Ethics 
 Modern ethical decision making in biomedical and related fields can be traced back to the 
philosophical discussions of ancient Greece and Rome.  Perhaps the best-known example of the 
fruits of these ethical discussions is the Hippocratic Oath, one of the earliest explicit ethical 
codes of conduct for medical professionals.  While the phrase ‘do no harm’ is arguably the most 
famous and memorable parts of the Oath, North’s (2010) translation perhaps best captures the 
essence of the Oath with, “ Into whatever homes I go, I will enter them for the benefit of the sick, 
avoiding any voluntary act of impropriety or corruption.”  The Oath also serves as a cohesive 
structure for early physicians, creating a professional structure akin to a family structure with 
one’s teacher seen as, “equally as dear to me as my parents,” and requiring that the student see 
his teacher’s children as, “equals to my own siblings, and to teach them this art, if they shall wish 
to learn it, without fee or contract,” (North, 2010).  The Oath also contains an exclusion criterion, 
stating that any physicians bound by the Oath would not teach their art to anyone who did not 
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also abide by the Oath, effectively limiting the ability of outsiders to draw from the Hippocratic 
lineage of knowledge of medicine and biology without accepting their ethical code.  
 Unfortunately, not all medical professionals since the inception of these concepts have 
been adherent to these same principles.  Many atrocities have been committed throughout history 
in the name of advancing science, leading ultimately to an ethical backlash against such acts and 
the development of more explicit ethical codes of conduct, especially with respect to biomedical 
research. 
The Nuremberg Code 
 Prior to and throughout the second World War, Nazi forces routinely captured and 
imprisoned individuals that did not conform to the ‘Aryan ideal’ espoused by leading figures of 
the Third Reich including a large number of Jewish individuals and families, Gypsies, political 
dissidents and individuals perceived to be homosexual.  These individuals were transported to 
concentration camps where they were forced to work in brutal and inhumane conditions that 
were justified by their captors as fitting of their sub-human status (Shirer, 1960).  At several 
specific sites, known best in modern times as the ‘death camps’, prisoners were experimented on 
by medical professionals, often in search of more efficient methods of euthanasia for those that 
did not fit the ideal model of genetics being dictated by the political will of the time.  Even after 
liberation of these camps, discoveries of euthanasia programs for the mentally ill and disabled 
that then became the foundation for these death camp programs well prior to the war came into 
international awareness (Lopez-Munoz et al., 2008). 
 At the end of the war, twelve military tribunals were convened in the city of Nuremberg 
in the southern German state of Bavaria.  These tribunals were created to hold accountable by 
rule of law those that had committed atrocities and war crimes among the defeated Axis forces, 
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particularly those among the then-dismantled Nazi party.  The first of these trials has been most 
commonly known as the ‘Doctors’ Trial’ but formally was recorded as United States of America 
v. Karl Brandt et al.  Of the twenty-three defendants, twenty were physicians who faced charges 
centered on conspiracy to commit or actually committing war crimes or crimes against humanity.  
The trial concluded on August 20, 1947 and resulted in seven acquittals, ten sentences ranging 
from ten years to life imprisonment and seven sentences of death by hanging (Lopez-Munoz et 
al., 2008).  The major perpetrators of much of the medical injustice had been tried and 
subsequently sentenced, yet the question of how to prevent such atrocities as came to light over 
the course of the trial remained. 
 During the Doctors’ Trial, Dr. Leo Alexander drafted and submitted six points defining 
‘legitimate medical research’ to the Counsel for War Crimes, which were adopted in the 
subsequent trial verdict with the addition of four more points.  These ten points became known 
as the Nuremberg Code (Trials of War Criminals before the Nuremberg Military Tribunals 
under Control Council Law No. 10, 1949).  Central to this document was the idea that human 
subjects should have ‘voluntary consent’ to any procedure and what information needed to be 
provided in order to ensure that the participant had enough information to give consent; it 
became the first internationally recognized code for research ethics and provided the foundation 
for future guidelines of research ethics (McCormick, 2005). 
The Declaration of Helsinki 
 While the Nuremberg Code offered considerable tools and new insights into how ethical 
research could be conducted in the future, this code in practice was difficult to apply.  To address 
growing concerns with this framework, in 1964 the World Medical Association (WMA) gathered 
100 delegates from 32 national-level medical associations in Helsinki, Finland.  The goal of the 
8 
 
delegates was to draft more comprehensive guidelines for human research, as well as to 
distinguish differences between therapeutic and non-therapeutic research (Corrigan, 2003).  The 
resulting document was named The Declaration of Helsinki, which reiterated the principles 
espoused by the Nuremberg Code while recognizing the difficulties faced by researchers in 
particular around the rigid structure of the Code.  In particular, the Declaration of Helsinki 
reinforced the need for participants in human research to have the “liberty to abstain from 
participation” and be “free to withdraw his or her consent to participation at any time” (World 
Medical Assembly, Declaration of Helsinki, 1964; section I., item 9) but relaxed the required that 
consent be “absolutely necessary” in all circumstances.  This shift was aimed at those studies in 
which full disclosure of all elements of the study could potentially bias the results, such as 
pharmaceutical studies in which knowledge on the part of the participant regarding their 
placement in either experimental or placebo conditions could bias their responding. 
 Additional aspects of the Declaration of Helsinki focused on human research, in 
particular how it is conducted, reviewed and disseminated.  Of particular importance to how 
research is conducted and reviewed, the Declaration of Helsinki was the first document to 
identify a need to consider the relationship between the risks and benefits of a given study.  The 
focus on potential risk to participants, as well as the recognition of the need for disclosure of risk 
to obtain truly informed consent, represented a major shift from previous ethical doctrines in 
terms in protection and empowerment of participants. 
 With regard to participants’ consent, the Declaration of Helsinki recommended that 
consent be obtained in writing.  This principle, while clearly and logically espoused in this 
document, was not put into widespread practice until unethical experiments began to be exposed 
by investigators and independent whistleblowers.  Several instances of experimentation on 
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people living in poverty and racial minority groups without their knowledge, and subsequently 
also without their consent, were brought into public awareness, forcing a shift towards collection 
of written consent among researchers and clinicians (Corrigan, 2003). 
 A major contribution to the process of reviewing research was the declaration’s 
recommendation of examination and review of human research studies by independent groups.  
While it did not create or dictate any specific regulatory agencies for this purpose, it laid the 
groundwork for creation of bodies such as institutional review boards for oversight of the 
research process. 
 Since the first Declaration of Helsinki was drafted by the World Medical Association in 
1964, there have been a total of five revisions, with the most recent having occurred in 2008.  
Early revisions focused primarily on relatively minor changes to address new considerations that 
arose naturally over time.  Examples of this included guidelines for seeking consent of minors 
when possible, further examining the potential functions of independent review committees, and 
statements regarding ethical treatment during international human research trials.  However, later 
revisions created considerable controversy, particularly over directives drafted around efficiency 
and utility of research (Stockhousen, 2000).  Major controversy emerged over the use of placebo 
drug trials and their ethical implications in international populations, particularly between 
developing versus developed countries (Nicholson, 2000).  However, the most recent revision 
(2008) has seen very little controversy emerge as it constituted a limited revision to the fifth 
revision (2000).  Additional controversy has sprung up over the differential application and 
reference to the declaration, especially around concerns with the United States’ Food and Drug 
Administration not recognizing any revisions since the third (1989) and eventual complete 
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abandonment of reference to the declaration in favor of its own ‘Good Clinical Practice’ guide 
(Obasogie, 2008). 
The Belmont Report 
 Arguably one of the most important pieces of literature pertaining to modern research 
principles, the Belmont Report of 1979 laid the groundwork for both the current concept of 
informed consent and many of the ethical principles underlying all current research using human 
subjects.  As part of the National Research Act of 1974, the National Commission for the 
Protection of Human Subjects of Biomedical and Behavioral Research was created not only to 
reassess the ethical principles that should be guiding biomedical and behavioral research, but 
also to develop procedures that allowed for adherence to these ethical principles.  After over four 
years of work, the commission put forth the Belmont Report (1979) which stood as a unique 
document for its time; the report provided a broad interpretation of ethical principles that allowed 
it to be used under a variety of both common and unique circumstances, which in turn set the 
precedence for the development of legal standards and professional codes of conduct.  The three 
broad principles set forth in the Belmont Report set the stage for the later development of current 
biomedical codes, as well as the APA Ethical Principles (2002).  
Respect for Persons 
The first principle is respect for persons, which refers primarily to respect for the 
autonomy of persons.  This principle aims to allow individuals to act in their own best interest, 
provided their interest is not clearly and directly harmful to others, and to provide additional 
protections for those who may have decreased autonomy due to factors such as immaturity, 
decreased cognitive ability, or incarceration.  While consent may still be gathered from these 
populations, this principle recognizes the need for special considerations to avoid infringing 
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upon these individuals’ rights and dignity.  In total, this principle makes impermissible to hinder 
individuals’ freedom to make careful and total consideration regarding their potential 
participation in studies without convincing reason. 
Beneficence 
The second principle defined is beneficence, which explicitly defined as researchers 
focusing their efforts on “doing good” or moving toward positive change.  However, underlying 
that factor is the idea that researchers should also attempt to avoid doing harm, though because 
of the nature of the majority of human research, in which the investigators are often looking for 
sources of harm, the aim then should be to maximize the good done while minimizing real or 
potential harm.  The search for this balance largely defines the process of risk assessment in 
research, focusing researchers on finding ways to do the most good with the least risk of harm in 
order to justify a study. 
 This often contradictory task of “doing good” while also “doing no harm” is frequently 
treacherous to navigate, though as almost all studies pose some even infinitesimal risk nearly all 
researchers must frequently navigate it.  Cases where participants may be placed at a greater-
than-minimal risk with no benefit to themselves but a potential for a longer-term benefit to 
society as a whole prove even more difficult to navigate.  While there is no clear and quantifiable 
definition of acceptable risk for harm in these cases, it is agreed that researchers must consider 
these questions with great care to meet the spirit of this principle. 
Justice 
The third and final principle is that of justice, a historically abstract concept that has 
resulted in great debate over time over what justice should look like in a societal context.  The 
Belmont Report roughly defines justice in a research context as an equal distribution of benefits 
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and burdens associated with research.  Even this more focused definition raises a series of 
difficult questions: How should benefit and burden be distributed?  Is it possible to truly equally 
distribute these concepts?  If not, how can they be distributed such that the core principle of 
justice is maintained?  These questions are not easily answered, and even when answered are 
subject to the whims and dictates of the current zeitgeist.   
While justice continues to be a difficult concept to apply even in the narrow lens of 
research, this principle in particular has lead the way for foundational changes in how research is 
reviewed and treated.  Entities such as institutional review boards, which help assess the 
ethicality of research being conducted, are themselves strongly rooted in the tradition of justice 
and serve as safeguards for potential participants in human research to ensure that benefit and 
risk are distributed in as balanced a manner as is possible.  These principles as a whole have 
created a foundation for the development of ethical guidelines for many professional bodies, 
including psychology as examined in the following section. 
Ethics in Modern Psychological Research 
 The American Psychology Association (APA) expanded on the principles set out in the 
Belmont Report (1979) by interpreting the original three principles and adding two new 
principles, as well as adding a series of specific ethical guidelines in the publication Ethical 
Principles of Psychologists and Code of Conduct (2002) and also as modified in 2010 (American 
Psychological Association, 2010). In addition to beneficence and nonmaleficence, justice, and 
respect for people's rights and dignity, which closely mirror the principles in the Belmont Report, 
the APA also added integrity as well as fidelity and responsibility to their ethical principles.  
These principles add additional weight to considerations in the process of informed consent for 
researchers, adding the ethical expectations of awareness of professional and societal 
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responsibilities, as well as an obligation to promote accuracy and honesty in our work (American 
Psychological Association, 2002).  This is especially meaningful for informed consent in 
deception studies, in which it is by definition impossible to fully inform the participant of what 
will occur in the research, which then places it in conflict with the principle of integrity.  To 
clarify this matter, the APA ethics code specifically addresses deception studies in section 8.07, 
stating, “(a) Psychologists do not conduct a study involving deception unless they have 
determined that the use of deceptive techniques is justified by the study’s significant prospective 
scientific, educational, or applied value and that effective non-deceptive alternative procedures 
are not feasible.”  This qualification allows deception studies to continue without creating 
methodologically crippling flaws through the process of informed consent, but still leaves the 
researcher with the obligation to rectify any mistrust resulting from the deception.  As an 
additional protection to participants, after all aspects of the study have been revealed the 
participants must be given the opportunity to withdraw their data to minimize potential harms 
experienced during the study (American Psychological Association, 2002, Sections 8.07 and 
8.08). 
 While the principles set forth by the APA are highly directive towards researchers and 
practitioners within the association, action at a federal level has also been taken to set guidelines 
and restrictions for all researchers.  In 1994 under then President Bill Clinton the National 
Bioethics Advisory Commission (NBAC) was developed to investigate alleged human research 
abuses and provide recommendations for the study of genetics.  The law put into place as a result 
of the NBAC's work, published under Annas, Glantz & Roche (1996), was entitled The Genetic 
Privacy Act of 1996.  A major consequence of this act was that it gave clear legal ownership of 
genetic samples to the individuals providing those samples.  Further, the Genetic Privacy Act 
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required researchers to obtain consent from participants to collect, store, analyze and further 
disseminate any genetic samples.  Unfortunately, while this laid out very clear guidelines for 
appropriate research using genetic material the NBAC did not have any means of enforcing these 
rules.  The more recent Genetic Information Nondiscrimination Act of 2008 is able to more 
directly enforce the prohibition of the use of genetic information in employment and health 
insurance determinations, it still leaves easily exploited loopholes in the areas of life insurance 
and long-term disability insurance. 
Risk Perception in Biomedical Research 
 Due to the limited nature of studies on perceptions of risk specific to behavioral genetic 
research, the primary focus of this section will be to review literature in the most closely related 
field to genetics: medicine.  In a study focusing on risks and compensation in clinical trials, 
Halpern et al. (2004) found several informative results relating to the biomedical and behavioral 
research fields.  First, they found a main effect showing that a higher potential risk in 
hypothetical placebo-controlled clinical drug trials related to a decrease in willingness to 
participate among potential volunteer participants in that study.  Additionally, by using a 
clustered ordinal logistic regression model, Halpern et al. (2004) found that willingness to 
participate in hypothetical placebo-controlled clinical drug trials decreased with lower monetary 
compensation, using proposed values between $100 and $2,000.  While the study is not readily 
generalizable to other fields of research, it does raise the long-contested question of how much 
money is required before monetary compensation becomes an unreasonably strong inducement. 
 Bentley & Thacker (2004) also found that across three levels of medical risk, pharmacy 
student research participants were less willing to participate at higher levels of potential risk.  
Levels of risk in this study were varied so that higher levels of risk involved clinical drug trials 
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(high risk involved a stage one, untested drug trial while medium risk involved a bioequivalency 
drug trial for a generic version of a common drug) while the low level of risk involved giving a 
saliva sample for a hormone check.  The study also discovered that lower levels of monetary 
compensation correlated with decreased willingness to participate.  Much like Halpern et al. 
(2004), this study focused primarily on medical risks, though this study required much longer 
required participation times to achieve the stated monetary compensation.  For the hypothetical 
major medical trials proposed in this Bentley and Thacker (2004) study, participants would need 
to stay under direct observation for two 24-hour periods in addition to participating in 12 half-
hour sessions.  The substantial monetary compensation in this study ranged from $350 to $1800, 
an hourly payment range of $6.48 to $33.00 per hour.  It is also important to note that the study 
included a no-payment condition in which there was significantly lower willingness to participate 
than other conditions. 
 Ascheman (2009) sought to follow up on Bentley & Thacker (2004), but aimed to 
specifically consider undergraduate students' concerns about their genetic privacy at varying 
levels of risk and monetary compensation.  In an attempt to elicit unfiltered information from 
students, the study used a number of deceptive elements, beginning with a 140-item personality 
questionnaire that was designed to appear to be the core component of the study.  In reality the 
questionnaire was merely a distractor leading up to a second study 'invitation' wherein subjects 
were given a second informed consent document for a study that would take place at a later date.  
The informed consent document itself was the actual manipulation, with each participant 
receiving one of two levels of risk to privacy, either high risk where the genetic sample donated 
in the second study would be identifiable as the participant and entered in an easily accessible 
national database, or low risk where the genetic sample donated would be stripped of identifying 
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information and entered into an experimenter restricted access repository that would be 
destroyed at the end of the researchers' work on this particular study.  The informed consent 
document also contained one of two levels of monetary inducements, either $10.00 or $100.00, 
provided that the sample was accepted into the repository.  As the repositories were fictitious and 
payment hinged on the acceptance of a participant’s sample being accepted into one of the 
repositories, no money was ultimately paid to participants though they were instead compensated 
with research credit for introductory psychology classes. 
 Ascheman's (2009) findings reflected many of the findings of Bentley & Thacker (2004), 
including a similar effect of risk and compensation on willingness to participate.  However, a 
notable difference that contradicted one of Ascheman's (2009) hypotheses was the presence of a 
statistically significant effect on perception of risk at different levels of monetary compensation.  
The study found that as monetary compensation increased participants' perceptions of the risks of 
the study decreased.  Due to the low level of comprehension among participants in Ascheman 
(2009), it is difficult to draw any conclusions about potential differences between the perceptions 
of risk in genetic studies compared to medical studies as examined in Bentley & Thacker (2004). 
However, this proposed study’s aim has been to explore the disparity between Bentley & 
Thacker (2004) and Ascheman (2009) by increasing comprehension of consent documents, 
clarifying differences between treatments, and establishing a baseline of risk perception at 
various levels of induced risk to loss of genetic privacy not confounded by compensation. 
 
Unique Features of this Study 
 In Ascheman's (2009) study, low comprehension of informed consent was observed for 
many participants, and it compromised the generalizability of findings.  This study’s aimed to 
elaborate on the topic of risk perception and monetary inducement in behavioral genetic research 
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through modifications and changes in methodology.  This study is unique in that it provided an 
assessment of how compensation affects perception of risk and how risk to privacy and monetary 
compensation affect willingness to participate in behavioral genetic studies. Through a mixed-
method approach, each participant was exposed to only one level of monetary compensation but 
both levels of risk to loss of privacy.  This design was used in hopes of gaining greater insight 
into the degree of impact from experimental manipulations in participants' perceptions of the 
potential loss of privacy of their personal genetic information through the use of the mixed 
within-between approach.  In addition, the study aimed to improve comprehension of informed 
consent by use of an alternate format for information presentation, a vignette story description. 
 This study used a short vignette format instead of the traditional format informed consent 
documents used in the previous study in an effort to improve participants' level of 
comprehension of the risks to privacy and monetary compensation.  While using actual informed 
consent documents would increase external validity and allow findings to be more readily 
generalized to informed consent occurring in current research, several challenges have been 
made to the current process of informed consent that must be considered.  Several studies have 
demonstrated that there is a significant disparity between the reading capabilities of participants 
and the reading level of many informed consent documents (Hammerschmidt & Keane, 1992; 
Hochhauser, 1999; Ogloff & Otto, 1991).  Early research by Sachs et al. (2003) demonstrated 
that even the average healthy adult participant may not have a sufficient capacity to fully 
understand some informed consent documents.  As such, this study chose to focus participants on 
potential risk, possible compensation, and to assess their willingness to participate by using a 
simple story-like paragraph vignette format. While this strategy may enhance comprehension, it 
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may reduce the generalizability of findings, as consent has been manipulated in a manner 
different than the usual IRB formatted documents.  
Statement of Purpose 
 The purpose of this study is to examine how undergraduate college students’ perceptions 
of risk to the privacy of their genetic information vary across several levels of risk of loss of 
privacy and monetary compensation.  This study has aimed to improve on previous research in 
this field in two aspects.  First, this study utilized a short vignette format to communicate the 
levels of risk and compensation.  While previous studies have utilized faux informed consent 
documents to communicate potential risks and degrees of compensation to participants, 
extremely low levels of comprehension were identified.  Ascheman (2009) summed up what 
many participants had to say when asked about their perceptions of the study with a single 
participant’s poignant response: “I didn't really pay attention that closely, I figured that the 
statements were the same for every study.”  As examining how participants perceive the 
informed consent process itself was beyond the scope of this study, this study instead chose to 
use short vignettes as the primary source of information about the hypothetical studies with the 
goal of presenting participants with a more brief and novel information process. 
 Second, this study used a mixed between-within subjects method that includes two 
treatment conditions containing baseline measures, or perception of risk without monetary 
compensation.  By adding a no-compensation level within the independent variable of monetary 
compensation the study aimed to develop an initial understanding of how participants perceive 
the levels of risk to the loss of their genetic privacy without the presence of any additional 
variables.  The addition of a baseline of risk perception has significantly disentangled the 
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independent variables and has allow for more direct analyses of the separate potential effects of 
money and risk on willingness to participate. 
 The goal of the overall project has been to gain insight into how monetary compensation 
affects perception of risk, and particularly how it may affect perception of risk to loss of genetic 
privacy.  While Bentley & Thacker (2004) did not find any effect of compensation on 
willingness to participate in medical drug trials, Ascheman’s (2009) findings appear to point to 
an effect of monetary compensation on risk perception with genetic sampling when examining 
data from those participants that could demonstrate comprehension of the study’s primary 
manipulation. As the literature appears to reveal a differential impact of monetary compensation 
based on the context of a given study, this study’s aim was to determine if there is an effect of 
monetary compensation separate from or in conjunction with presented risk information 
accorded to potential research participants in behavioral genetic studies.  These findings may 
help create a more clear understanding of these differences for ethical bodies such as Institutional 
Review Boards, such that they may be able to make more informed decisions about research 
projects. 
 
Hypotheses 
Willingness to Participate with Joint Consideration of Risk and Compensation 
● Hypothesis1: Willingness to participate (WTP) will differentially increase as 
compensation increases in both high risk and low risk conditions. 
●  A test of this interaction hypothesis will determine whether increased 
compensation differentially leads to increases in participants’ willingness to 
participate in behavioral genetic studies across both levels of associated risk to 
genetic privacy.  This interaction hypothesis is indicated on Diagram 1 as depicted by 
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the difference between the two points (greater difference in ratings of willingness to 
participate) in the high compensation condition compared the lesser difference 
between the two points in the low compensation (smaller difference in ratings of 
willingness to participate).  
● Analysis: Two separate 2x2 mixed ANOVAs were conducted. One was 
performed on of each of the two willingness to participate questions (‘After reading 
the description, how willing would you be to participate in this study?’ and ‘How 
likely would other students like you be to participate in this study?’). These analyses 
were conducted using compensation as a between-subjects measure and risk as a 
within-subjects measure in order to determine if there were significant interactions 
between level of risk and level of compensation.  
● Hypotheses 1A and 1B: 
● 1A. There will be a main effect of risk on WTP. 
● 1B. There will be a main effect of money on WTP. 
● Analysis: Main effects analyses were conducted to test whether there was 
an effect of risk across both levels of compensation and to determine if there was 
a separate effect of money across both levels of risk. 
Perception of Risk with Joint Consideration of Risk and Compensation 
● Hypothesis 2: Risk Perception will differentially increase as compensation increases in 
both high risk and low risk conditions. 
● This interaction hypothesis will determine whether increased compensation 
differentially leads to increases in participants’ perception of risk to loss of privacy in 
behavioral genetic studies across both levels of associated risk to genetic privacy.   
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The proposed model for willingness to participate in 
behavioral genetics studies at varying levels of 
monetary compensation. 
Compensation 
Low High 
Willingness 
To Participate 
Low 
High 
High Risk x No Compensation 
Low Risk x $100 Compensation 
High Risk x $100 Compensation 
Low Risk x No Compensation 
Diagram 1 
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● Analysis: Two separate 2x2 mixed ANOVAs were conducted. One was 
performed on each of the two risk perception questions (‘How concerned are you 
regarding the loss of the privacy of your personal information in this study?’ and 
‘How much risk to your privacy do you feel it is to have your DNA sample put in the 
repository being used for this study?’). These analyses were conducted using 
compensation as a between-subjects measure and risk as a within-subjects measure in 
order to determine if there were significant interactions between level of risk and 
level of compensation.  
 Hypotheses 2A and 2B: 
● 1A. There will be a main effect of risk on Risk Perception. 
● 1B. There will be a main effect of money on Risk Perception. 
● Analysis: Main effects analyses were conducted to test whether there was 
an effect of risk across both levels of compensation and to determine if there was 
a separate effect of money across both levels of risk. 
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CHAPTER 3 
METHOD 
Design 
 The independent variables in this online study are risk to privacy and monetary 
compensation.  The study used a 2 (level of risk to privacy) by 2 (level of compensation) mixed 
design, with level of risk to privacy as a within subjects measure and level of compensation as a 
between subjects measure. Thus all participants received both high and low levels of risk but 
were randomly assigned to either a high or low compensation condition.  Levels of risk to 
privacy are defined as either high risk in which participants were told, by an investigator 
constructed informed consent, that the fictitious researchers will be entering a person’s 
identifiable genetic data into a national repository for which multiple researchers, privately 
funded research groups, life and medical insurance companies, as well as local and national law 
enforcement agencies, will have access.  In contrast in the low risk condition, participants were 
informed by the consent document that the fictitious researchers will be entering genetic data 
stripped of all identifiers into a repository database that will be destroyed after five years and 
only be accessible to those researchers associated with the study.   
Levels of compensation are defined as none ($0 for participation) or high ($100 for 
participation).  While the high ($100) condition was identified as an appropriate level in the pilot 
study for Ascheman (2009), the additional no compensation ($0) condition was added to this 
study to serve as a baseline for perception of risk.  By adding this new condition the study has 
attempted to create a quantifiable perception of risk without having any monetary compensation 
potentially influencing participants’ responses, which was one of the major difficulties 
encountered by Ascheman (2009).  Each participant received one of four possible treatment 
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orders designed to counterbalance the order in which participants will respond to each vignette.   
This counterbalanced order was used to deal with possible carryover and differential carryover 
effects by having each vignette viewed in each possible order a roughly equal number of times 
across the whole data set (see Table 1).  In essence, this means that participants will be randomly 
assigned to one of four possible treatment orders with an approximately equal number of 
participants in each treatment order.  Please also see Figure 1, the Flow Chart Diagram-Sequence 
of Experimental Tasks (Page 33 or Appendix A). 
 
Treatment Orders 
Table 1. Treatment orders. All conditions were balanced so that 
each level of risk is received an equal number of times in both 
possible orders. 
 
$0 Condition 1 Low Risk x $0 High Risk x $0 
  2 High Risk x $0 Low Risk x $0 
    $100 Condition 3 Low Risk x $100 High Risk x $100 
4 High Risk x $100 Low Risk x $100 
 
 
A brief open-ended comprehension check (Appendix B) was placed after each vignette 
was presented.  This assessment of comprehension, in addition to the initial instructions that 
introduce the vignettes  and urge  participants take their time and read each  one carefully in 
order to render their most informed impressions, was aimed to prime participants to pay close 
attention to the different details of each study. In addition these procedures provide the 
researchers with the ability to check if participants were attending to the manipulations of the 
independent variables.   
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 The dependent variables in this study are perceived risk and willingness to participate.  
The questionnaire used to measure the perceived risk and willingness to participate variables 
(Appendix C) were been adapted from Ascheman (2009) after a post hoc factor analysis of the 
original questionnaire demonstrated that the groupings of questions for perceived risk and 
willingness to participate appeared to indeed be distinctly and independently measuring separate 
variables  (Appendixes D, E and F).  Two questions for each variable were selected based on the 
factor analysis and modified for use in this study (Appendix C). 
Participants 
 Based on the power analysis using the GPower3 program, this study aimed to collect at 
least 112 participants in order to achieve a power of at least .80 and a significance level of .05.  
All participants were students enrolled in introductory level psychology or communications 
studies courses at a single large Midwestern university.  Participants enrolled in the study 
through the psychology department's online research system, the SONA system, and received 
experimental study credit in their introductory psychology or communications studies courses.  
This study was reviewed and approved by the Iowa State University IRB (IRB Number 12-172; 
approval date 03/20/2012, see Appendix G). All participants were given the option to complete 
studies for credit in these courses or to complete brief writing assignments as an alternative.   
 There were 189 response collected in this online Qualtrics study. Of those respondents, 
three chose to not complete the study after reading the informed consent document and had their 
responses removed from the data set.  An additional 21 participants agreed to participate but 
either stopped the survey after completing the demographics questionnaire or did not respond to 
any questions after the informed consent presentation and their responses were also removed 
from the data set.  This left a total of 165 respondents, all of whom completed a minimum of 
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seven of eight questions related to the main manipulation.  The between subjects measure, level 
of compensation, yielded a total of 81 responses at the $0 compensation level and 86 responses 
at the $100 compensation level. 
 Of the 166 participants with valid responses, 121(72.9%) were between the ages of 18- 
20, an additional 31 (18.7%) between the ages of 21-22, and 14 (8.4%) between ages 23-26.  No 
participants identified as older than 26 years of age.  Due to an error in the survey, gender data 
was not collected for all participants.  Of the 89 responses collected for gender, 45 (50.6%) 
identified as male and 44 (49.4%) identified as female.  Caucasian/European Americans were the 
most frequent participants (131 or 78.9%). Five participants (3%) identified as Black or African 
American, five (3%) as Hispanic or Latino/a, 19 (11.4%) as Asian or Asian American, five (3%) 
as Multiracial, and one (0.6%) identified as Other.  Participants were also asked if they had ever 
undergone genetic testing or genetic counseling; eight participants (4.8%) reported that they had 
experienced testing or counseling.  Among the participants, the majority (100, 60.6%) reported 
having completed five or more research studies previously, with only 32 (19.6%) having 
completed three to four studies previously, and 31 (19%) having completed two studies or fewer.   
The participants reflected a broad sampling of volunteers from the courses included in the 
Psychology Department subject pool. There were 48 (29%) from Psychology 101, 51 (30.9%) 
from Psychology 230, 33 (20%) from Psychology 280 and 32 (19.4%) from Communication 
Studies 101, with one participant choosing not to respond to this question. 
Measures 
Independent and Dependent Variables and Measures 
 The independent variables in this study are risk to privacy and monetary compensation.  
The study used a 2x2 factorial mixed design with each subject receiving one level of monetary 
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compensation and both levels of risk to privacy.  The independent variable of monetary 
compensation is defined as either no monetary compensation ($0) or high monetary 
compensation ($100.00), and the independent variable of risk to genetic privacy is defined as 
either high (identifiable genetic data stored in databases accessible to law enforcement, insurance 
agencies and other researchers) or low (genetic data stripped of identifiers and stored in a secure 
database accessible only to the researchers that will be destroyed after five years). 
 The dependent variables in this study are perceived risk and willingness to participate.  
Perceived risk was measured using a modified questionnaire from Ascheman's (2009) study, 
using two self-report questions (‘After reading the description, how willing would you be to 
participate in this study?’ and ‘How likely would other students like you be to participate in this 
study?’) with lower scores indicating a lower perception of risk.  Willingness to participate was 
measured using two self-report questions modified from Ascheman's (2009) study (‘How 
concerned are you regarding the loss of the privacy of your personal information in this study?’ 
and ‘How much risk to your privacy do you feel it is to have your DNA sample put in the 
repository being used for this study?’), with lower scores indicating a lower willingness to 
participate (Appendix C).  These dependent variables were measured on a six point Likert-type 
scale. 
 The study additionally utilized a simple two question free response comprehension check 
after each vignette was presented (Appendix B).  This comprehension will served two central 
purposes.  The first was to assess whether or not participants are aware of the central features of 
each vignette, namely risk of loss of privacy (assessed with “Will your information be shared 
with people other than the researchers?”) and presence of monetary compensation (assessed with 
“How much will you be paid to participate in this study?”).  The second central purpose will be 
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to prime participants to attend to this particular information in each vignette more carefully with 
the aim of increasing comprehension of the central manipulations in each vignette. 
Other Measures 
 Social Desirability. This study uses primarily self-report measures.  Hence, a social 
desirability measure was added to assess participants’ degree of social desirability in responding, 
their likelihood of self-enhancement.  The 10-item Marlowe Crowne Social Desirability Scale, 
developed by Strahan and Gerbasi (1960) was chosen for this study due to concise nature, aiming 
to control against fatigue effects, as well as its well-established psychometric background 
(Appendix H).  Responses were given in a true-false format, with half of the questions having a 
true response indicative of socially desirable responding and half reverse-coded so that a false 
response would indicate socially desirable responding.  Scores on this scale range from 0-10, 
with higher scores indicating more socially desirable responding.  Alpha coefficients for the 10-
item Marlowe-Crowne range from .59 to .70, with the original comparison sample to the full 
item Marlowe-Crowne achieving correlations between .80 and .90.   
 Five-factor model of personality. For purposes of future analyses with this data set, the 
International Personality Item Pool version of the NEO Personality Inventory Revised (IPIP-
NEO) was been included.  The NEO-IP-R was developed by Coast & McCrae (1992) using 
factor analysis to identify the five personality domains of Extroversion, Agreeableness, 
Conscientiousness, Neuroticism and Openness to Experience.  The original NEO-IP-R additional 
breaks each of these five factors into six sub-scales for each domain, totaling thirty sub-domains. 
 The IPIP-NEO was developed by Goldberg (1999, 2006) using a similar factor analysis 
process that was used to develop the NEO-IP-R.  The goal of the development of this new 
version was to create a publicly available personality measure with a smaller item pool that has 
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strong correlations to the full NEO-IP-R, as well as similar validity across genders and several 
ethnic groups (Ehrhart et al., 2008).  Correlations between these two measures average 0.77, 
though this increases to 0.90 when correcting for unreliability attenuation (see 
http://ipip.ori.org/newNEO_DomainsTable.htm).  The IPIP-NEO is available in long- and short-
form versions, with the long-form maintaining all thirty sub-domains originally assessed by the 
NEO-IP-R.  For the purpose of this study, the 50-item short form of the IPIP-NEO has been 
selected (Appendix I).  Normative sampling has been completed with over 20,000 individuals 
and internal reliability for all five major personality domains range from 0.77 to 0.86 (see 
Appendix J). 
 Descriptive analyses of the IPIP-NEO demonstrated fairly normal distributions of scores 
across each of the five subdomains.  Minimum scores on all five measures ranged from 22 to 24 
and maximum scores ranged from 38 to 41 out of possible scores between 10 and 50.  The 
lowest mean and median scores were in Neuroticism (m = 28.93, median = 29) while the highest 
mean and median scores were in Conscientiousness (m = 31.55, median = 32).  Standard 
deviations were also very close to one another, ranging from a low of 2.75 (Neuroticism) to 3.30 
(Extraversion).  These scores were comparable to previous NEO scores from the SONA research 
pool.  As these scores did not appear to show any major deviations from a normal distribution, 
no further analyses were conducted on this part of the data for the purposes of this study. 
 Risk perception and willingness to participate.  In order to measure the two dependent 
variables at the core of this study (perception of risk and willingness to participate), questions 
were developed specifically for the purpose of this study by modifying questions from 
Ascheman’s (2009) original work.  Ascheman's questionnaire demonstrates two strong 
underlying factors that can be identified as risk perception and willingness to participate (see 
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Appendixes D, E and F).  These two factors are weakly correlated (r² = -.19) and demonstrate 
strong reliability (α = .76 for risk perception, α = .80 for willingness to participate) and so were 
chosen for use in this study's modified questionnaire.  The questionnaire consisted of the two 
strongest items from the risk perception and willingness to participate variables previously 
identified, with responses given on a six-point Likert-type scale.  This questionnaire will be 
given following each vignette (see Appendix C for the questionnaire and Appendix K for a full 
vignette). 
 Research Attitudes.  Two measures for collecting information regarding participants’ 
attitudes towards research, and specifically attitudes toward genetic research, were developed for 
this study.  The first measure is an eight-item questionnaire that assesses attitudes toward 
research and research participation, and their experience as a research participant (Appendix L): 
the first item asks participants for an open response regarding what they view as most important 
to them in deciding whether or not to participate in a study, the second through fourth items 
gauge participants’ amount of previous exposure to research, and questions five through eight 
assess participants’ attitudes towards research on a five-point Likert-type scale.  The second 
measure is a brief free-response item asking participants to briefly describe their attitude towards 
genetic research (Appendix M; “What do you think are the advantages and risks associated with 
scientific research on genetics?“). 
Procedure 
 Participants were recruited through the university's SONA online research system (see 
SONA Posting Form, Appendix N).  Those who elected to participate in the study were directed 
by web link to the study survey hosted on the university’s Qualtrics program.  Participants first 
viewed an informed consent document, in which they were informed that their participation was 
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entirely voluntary and they would free to withdraw from the study at any time without penalty 
(see Informed Consent, Appendix O).  The consent provided a deceptive description of the study 
(selected elements of purpose were omitted) in which participants were informed that this study 
aimed to examine psychology students' perceptions of upcoming behavioral genetic studies in an 
effort to understand and address students’ potential concerns about the proposed studies before 
the studies received approval.  After reading the informed consent the participants were asked to 
indicate “yes” or “no” to providing their online consent, stating also that by providing consent 
they attested that they had read the informed consent and understood what was being asked.
 After completing the informed consent procedure, participants who did not give consent 
were redirected to a page debriefing them and thanking them for their time.  Those that gave 
consent were directed to the primary survey.  Participants first responded to a demographics 
questionnaire (Appendix P) before being directed to a research attitudes questionnaire developed 
for this study (Appendix L).  Once participants had responded to these two questionnaires, they 
were randomly assigned through a Qualtrics randomization feature to one of two compensation 
treatment conditions, either no compensation ($0) or high compensation ($100).  They were then 
again randomly assigned by a Qualtrics randomization feature to see either the high risk or low 
risk condition first (see Table 1, page 24).  
They were then given a set of instructions to prime them to attend carefully to each of the 
vignettes (Appendix K) that were being presented.  Participants were then presented with the 
first vignette to which they been assigned, after which participants answered two brief open 
ended comprehension questions (Appendix B).  In addition, there was one additional 
comprehension question presented after the vignette for the high risk and no compensation (high 
risk x $0) condition, specific to this condition regarding their perception of the risks associated 
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with the study. Following the comprehension questions, four questions derived from Ascheman 
(2009) regarding participants’ perceptions of the risks and willingness to participate were 
presented (Appendix C).   
 After viewing the first vignette, participants were presented with the Marlowe-Crown 10-
item Social Desirability Scale (Strahan & Gerbasi, 1972), a task designed to gather additional 
information (Appendix H). Presentation of this scale was also intended to separate the vignettes 
so as to minimize inattentive “same responding” across vignettes, to foster attention to the 
content of each vignette by requiring the participant to shift attention and cognitive focus, as well 
as to help prevent fatigue.  Following the final vignette questionnaire, participants were asked to 
complete the 50-item version of the IPIP NEO, a short scale designed to measure the five major 
personality traits of openness to new experiences, conscientiousness, extroversion, agreeableness 
and neuroticism (Appendix I). This version of the NEO has strong, multiple, and domain specific 
correlations to the full NEO personality scale measures (Costa & McCrae, 1992).  Finally, 
participants were asked to engage in a brief free-writing exercise to assess their beliefs about the 
advantages and risks associated with studying behavioral genetics (Appendix M). 
 After completing the questionnaires, participants were directed to a debriefing form 
(Appendix Q) designed to explain the true nature of the study, as well as the focus and purpose 
of the research. Participants were then shown a two-page brochure regarding genetic testing, 
privacy protections, and informed consent (Appendix R).  The sequence of participant tasks is 
conveyed by the flowchart displayed in Figure 1 (Page 33).  Appendix A contains the flowchart 
of the all measures being used and their relative positions throughout the study as seen in Figure 
1.  A full set of all vignette variations can be found in Appendix S.  This study and all materials 
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were reviewed and approved by the Iowa State University Institutional Review Board before 
data were collected (IRB Number 12-172; approval date 03/20/2012, see Appendix G). 
  
34 
 
 
  
Potential Participants view description of 
study on SONA system. 
Informed Consent Document  
(Appendix O) 
Demographics Questionnaire 
(Appendix P) 
Research Attitudes Questionnaire 
(Appendix L) 
$0 
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Low Risk x 
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$0 
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Low Risk x 
$0 
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Low Risk x 
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Research Attitudes Writing Task 
(Appendix M) 
Debriefing 
(Appendix Q) 
Figure 1: Study Flowchart 
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CHAPTER 4 
RESULTS 
Preliminary Analyses 
Data Cleaning 
 In this study, 189 individuals chose to participate by signing up through the university’s 
SONA research system.  Of those 189 persons, three chose not to continue participation after 
reading the informed consent document.  An additional 21 participants either completed only the 
demographics questionnaire or did not answer any questions.  After removing data points for 
individuals who did not consent to participate and those who did not complete the survey beyond 
the initial demographics questionnaire, data for 165 participants remained.  All of these 
participants answered at least six of the eight questions related to willingness to participate and 
perception of risk, the main dependent variable measures for this study, and so were retained for 
further data analysis.  Of these remaining 165 participants, the groups were nearly equal for 
those exposed to the two levels of the between subjects measure condition, monetary 
compensation (n=81 for $0 condition, n=85 for $100 condition).  
Tests for Normality and Homoscedasticity 
 All four dependent variable measures (two measures of risk and two measures of 
willingness to participate) were examined to determine if they met the necessary assumptions for 
carrying out analysis of variance testing, with each variable measure being tested within its 
between-subjects split of level of compensation.  Levine’s test of homogeneity of variance 
demonstrated no significant heterogeneity in the variances of any of the dependent variable 
measures at any compensation levels (see Appendix T).  However, all levels of the dependent 
variables demonstrated significant non-normality (see Appendix U).  Several articles have 
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indicated that such variations in normality do not have strong effects on finding false positive 
significance when using analysis of variance (Glass et al., 1972; Harwell et al., 1992; Lix et al., 
1996) and so plans to use an ANOVA method for analysis were maintained.  All dependent 
variables at both levels of risk were also examined for inter-correlations, and demonstrated 
similar correlation levels to results from Ascheman (2009) (see Appendix V) 
Social Desirability Correlation 
 As this study relied on self-report measures, the 10-item Marlowe-Crowne Social 
Desirability Scale (Strahan & Gerbasi, 1972) was also given to all participants in order to assess 
for socially desirable responding that may have affected the ways in which participants 
responded to questions about their potential willingness to participate in studies.  Correlations 
between each of the dependent variables at both levels of the between subjects variable, 
compensation, and social desirability demonstrated no significant correlations (see Table 2), and 
as such plans to use social desirability as a covariate in analyses were discarded. 
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$0 Condition 
  
   $100 Condition 
 WTP1xLow Pearson 
Correlation 
.088 
 
WTP1xLow Pearson 
Correlation 
-.042 
Sig. (2-tailed) .458 
 
  Sig. (2-tailed) .706 
WTP2xLow Pearson 
Correlation 
.117 
 
WTP2xLow Pearson 
Correlation 
-.135 
Sig. (2-tailed) .321 
 
  Sig. (2-tailed) .228 
RiskP1xLow Pearson 
Correlation 
-.065 
 
RiskP1xLow Pearson 
Correlation 
.057 
Sig. (2-tailed) .581 
 
  Sig. (2-tailed) .611 
RiskP2xLow Pearson 
Correlation 
-.097 
 
RiskP2xLow Pearson 
Correlation 
-.002 
Sig. (2-tailed) .412 
 
  Sig. (2-tailed) .987 
WTP1xHigh Pearson 
Correlation 
.115 
 
WTP1xHigh Pearson 
Correlation 
-.032 
Sig. (2-tailed) .329 
 
  Sig. (2-tailed) .777 
WTP2xHigh Pearson 
Correlation 
.013 
 
WTP2xHigh Pearson 
Correlation 
-.108 
Sig. (2-tailed) .915 
 
  Sig. (2-tailed) .333 
RiskP1xHigh Pearson 
Correlation 
.023 
 
RiskP1xHigh Pearson 
Correlation 
.100 
Sig. (2-tailed) .849 
 
  Sig. (2-tailed) .371 
RiskP2xHigh Pearson 
Correlation 
-.044 
 
RiskP2xHigh Pearson 
Correlation 
.054 
Sig. (2-tailed) .712 
 
  Sig. (2-tailed) .629 
N = 74 
 
N = 82 
       
 
Table 2: Correlations between dependent variables and social desirability scale, 
separated by between-subjects condition (compensation). 
Social Desirability Correlations 
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Descriptive Statistics 
Research Attitudes Questionnaire 
 The research attitudes questionnaire developed for this study assessed individuals’ 
attitudes about several aspects of research and the research participation process prior to being 
exposed to any manipulations.  A question regarding the importance of money in decisions 
whether or not to participate in studies (‘How important is money in your decision to participate 
in studies?’) demonstrated strong participant beliefs that money was not important in their 
decision making process with research.  Ninety participants (54.9%) rated money as not at all 
important or unimportant (indicated as one or two on the presented scale), with an additional 49 
(29.9%) rating money as somewhat important in their decisions (three on the scale).  Only 25 
participants (15.3%) rated money as important or very important in their decision to participate 
in studies (four or five on the scale; scale total M = 2.45, SD = 1.04, N = 164).  Participants were 
also asked to rate how serious loss of privacy would be in a study (‘How serious would you loss 
of privacy in a study be?’) on a one (not at all serious) to five (very serious) scale.  Only 15 
participants (9.1%) rated a loss of privacy as not at all serious or not serious; 37 participants 
(22.4%) rated this as somewhat serious and 113 (68.5%) rated a potential loss of privacy as 
serious or very serious (total scale M = 3.85, SD = .93, N = 165). 
 Participants also responded to a question about their perceptions of general risk in genetic 
studies (‘How risky are studies in which genetic samples are taken?’).  A majority of participants 
(84, 51.2%) rated genetic studies as somewhat risky, with 42 (25.4%) rating them as not at all 
risky or not risky and 28 (23.1%) considering them to be risky or very risky (total scale M = 
2.99, SD = .80, N = 164).  Overall, participants seem to indicate on this scale that tend to believe 
they are not strongly influenced by money in decisions to participate in research studies and have 
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fairly high concern for the seriousness of loss of privacy with only mild concerns about genetic 
studies.  See Table 3 below for a complete list of the descriptive statistics for this section of the 
research attitudes questionnaire. 
 
Table 3: Research Attitudes Questionnaire Descriptive Statistics 
   
 
Item M SD Range 
Enjoy Research 
Participation 
3.01 .77 1 (Do not enjoy) - 4 (Enjoy) 
Importance of 
Money for 
Participation 
2.45 1.04 1 (Not at all important) - 5 (Very important) 
Value of Research 
to Education 
2.96 .91 1 (Not at all valuable) - 5 (Very valuable) 
Seriousness of 
privacy loss 
3.85 .93 1 (Not at all serious) - 5 (Very serious) 
Risk of Genetic 
Studies 
2.99 .80 1 (Not at all risky) - 5 (Very risky) 
 
 
 IPIP-NEO Personality Scale 
 Descriptive statistics were generated for each of the five personality factors measured by 
the 50-item IPIP-NEO scale.  All five scales demonstrated remarkably similar means and 
variances. Minimum scores on all five measures ranged from 22 to 24 and maximum scores 
ranged from 38 to 41 out of possible scores between 10 and 50.  The lowest mean and median 
scores were in Neuroticism (m = 28.9324, median = 29) while the highest mean and median 
scores were in Conscientiousness (m = 31.5461, median = 32).  Standard deviations were also 
very similar, ranging from a low of 2.752 (Neuroticism) to 3.297 (Extraversion).  These findings, 
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based on a frequency histogram plot, appear to indicate a fairly normal distribution for each of 
the five scores.  These scores were also correlated with the dependent variables to determine if 
any personality measures would be appropriate for use a covariates in further analysis.  None of 
these correlations were statistically significant (see Appendix W). 
Open-Ended Risk and Compensation Perceptions 
 After reading each vignette but before responding to the dependent variable questions, 
participants were asked to write in how much they would be compensated for participation in the 
presented study vignette (‘How much would you be paid to participate in this study?’) as well as 
whether or not their information would be kept confidential (‘Will your information be shared 
with people other than the researchers?’).  In Ascheman’s (2009) study, comprehension checks 
similar to these yielded a comprehension rate of approximately 14%.  
However, in this study, initial conservative analyses of these comprehension questions, 
which only considered a response as a correct, accurate comprehension response (stated exactly 
the correct amount of compensation) or directly and correctly stated the risk (whether or not 
information would be shared with parties other than the researchers) indicated very positive 
results.  Of the 165 participants, 133 (80.5%) were able to correctly identify the amount of 
compensation indicated in the low ($0) compensation condition, and 130 (78.8%) correctly 
identified that correct amount of compensation in the high ($100) condition.  Of those who 
responded correctly, 121 (73.3% of the total sample) correctly identified the amount of 
compensation in both vignettes they viewed, while 19 (11.5% of the total sample) correctly 
identified only one of two compensation amounts in the vignettes they viewed. 
 Comprehension of questions regarding who else data may be shared with showed 
similarly strong comprehension ratings.  Participants correctly identified that their information 
41 
 
would not be shared outside of the immediate research in 139 of 165 responses (84.24% 
comprehension) in the low risk condition, and 103 participants (62.42%) correctly identified that 
their information would be shared with people other than the researchers in the high risk 
condition.  These comprehension rates are substantially higher than those found in the results of 
Ascheman (2009). The implications of these findings will be further explored in the discussion 
section of this thesis. 
Hypothesis 1: Willingness to Participate 
Hypothesis 1: Interaction of Risk x Compensation on WTP 
 In order to assess for an interaction effect between amount of compensation and level of 
risk to loss of genetic privacy, separate 2x2 mixed ANOVAs were conducted on both 
Willingness to Participate dependent variable measures.  The first WTP measure (‘After reading 
the description, how willing would you be to participate in this study?’) did not have a 
significant interaction effect (F (1, 160) = .04, p = .84).  The second WTP measure (‘How likely 
would other students like be to participate in this study?’) also did not have a significant 
interaction effect (F (1, 162) = 0.00, p = .99).  These findings suggest that level of monetary 
compensation does not have a differential effect on willingness to participate at different levels 
of risk.  This finding does not support one of the original hypotheses of this study, namely that 
willingness to participate would be more strongly influenced by monetary compensation in the 
high risk condition than in the low risk condition, in essence causing participants to ignore more 
of the risks that are more strongly present in that condition and as such be more willing to 
participate (see Diagram 2 for comparison of models). 
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Compensation 
Low High 
Willingness 
To Participate 
Low 
High 
High Risk x No Compensation 
(m = 2.77, sd = 1.68) 
Low Risk x $100 Compensation 
(m = 4.44, sd = 1.27) 
High Risk x $100 Compensation 
(m = 3.04, sd = 1.57) 
Low Risk x No Compensation 
(m = 4.23, sd = 1.21) 
Compensation 
Low High 
Willingness 
To Participate 
Low 
High 
High Risk x No Compensation 
Low Risk x $100 Compensation 
High Risk x $100 Compensation 
Low Risk x No Compensation 
Diagram 2: Results Model of WTP1 (Top) and Original Hypothesis Model (Bottom) 
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Hypothesis 1A: Main Effect of Risk on WTP 
 Analyses of main effects were carried out on both WTP questions following interaction 
testing.  The first WTP measure (own willingness to participate) demonstrated a strong main 
effect of risk (F (1, 160) = 101.43, p < .01) with a fairly large effect size in both the no 
compensation (d = 0.99, r = 0.45) and the $100 compensation (d = 0.98, r = 0.44) conditions.  
The second WTP measure (perceived willingness of others) also demonstrated a strong main 
effect of risk (F (1, 162) = 103.03, p < .01) and similarly large effect sizes in both no 
compensation (d = 0.96, r = 0.43) and $100 compensation (d = 0.97, r = 0.44) conditions, both of 
which are considered large effect sizes (Cohen, 1988).  These findings support the original 
hypothesis and suggest that the levels of risk presented in the vignettes had a powerful effect on 
participants’ willingness to participate and perceptions of others’ willingness to participate in the 
each vignette study. 
Hypothesis 1B: Main Effect of Money on WTP 
 Analyses of main effects from the 2x2 ANOVA for monetary compensation yielded 
mixed results across both WTP measures. An analysis of WTP on participants’ own willingness 
to participate did not reveal a significant main effect of monetary compensation (F (1, 160) = 
1.97, p = .16) though given the sample size and near-significance of the finding, it is possible 
that a larger sample size may be able to detect a small main effect. An analysis of WTP for 
participants’ perceptions of others’ willingness to participate, however, did yield a significant 
main effect of monetary compensation (F (1, 162) = 4.77, p = .03) with a small effect size (d = 
0.31, r = .15) as defined by Cohen (1988).  Thus, the findings suggest that participants are not 
significantly affected in their own decision of willingness to participate in the vignette studies by 
levels monetary compensation presented in this study. However, the data also suggest that these 
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participants believe others would be more influenced by the levels of monetary compensation 
than they indicate for themselves. These findings will be explored in greater depth in the 
discussion section of this paper. 
Hypothesis 2: Perception of Risk 
Hypothesis 2: Interaction of Risk x Compensation on Risk Perception 
 Additional 2X2 mixed ANOVAs were conducted on both measured risk perception 
variables to assess for interaction effects between level of risk and monetary compensation.  
Analysis of the first risk perception measure (‘How concerned are you regarding the loss of the 
privacy of your personal information in this study?’) did not detect an interaction effect (F (1, 
162) = 1.89, p = .17).  Similarly, analysis conducted on the second risk perception measure 
(‘How much risk to your privacy do you feel it is to have your DNA sample put in the repository 
being used for this study?’) also did not show any significant interaction effect (F (1, 163) = 
2.76, p = .10).  As was found with analysis of willingness to participate variables, these findings 
do not support the original hypothesis that increased compensation would differentially affect the 
perception of the risks across the vignettes, leading to more substantially decreased perception of 
risk in higher compensation conditions. 
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Table 4: Descriptive matrices grouped by Dependent Variable [M(SD)] 
 
        
   WTP1 
 
RiskP1 
 
 
High Risk Low Risk 
  
High Risk Low Risk 
 
$0  
2.77 
(1.684) 
4.23 
(1.208) 
 
$0  
4.37 
(1.602) 
2.77 
(1.527) 
 
$100  
3.04 
(1.571) 
4.44 
(1.274) 
 
$100  
4.25 
(1.542) 
3.04 
(1.484) 
 
        WTP2 
 
RiskP2 
 
 
High Risk Low Risk 
  
High Risk Low Risk 
 
$0  
2.79 
(1.515) 
4.06 
(1.102) 
 
$0  
4.35 
(1.450) 
2.90 
(1.411) 
 
$100  
3.15 
(1.393) 
4.42 
(1.219) 
 
$100  
4.01 
(1.570) 
3.01 
(1.376) 
 
        
WTP1: After reading the description, how willing would you be to participate in this study? 
        
WTP2: How likely would other students like you be to participate in this study? 
        
 
1 - Not at all Willing / Likely; 6 - Very Willing / Likely 
  
        RiskP1: How concerned are you regarding the loss of the privacy of your personal information 
in this study? 
        RiskP2: How much risk to your privacy do you feel it is to have your DNA sample put in the 
repository being used for this study? 
        
 
1 - Not at all Concerned / Risky; 6 - Very Concerned / Risky 
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        Risk Level Compensation WTP1 WTP2 RiskP1 RiskP2 
  
        
Low Risk $0  4.23 4.06 2.77 2.9 
  
  
(1.208) (1.102) (1.527) (1.411) 
  
 
$100  4.44 4.42 3.04 3.01 
  
  
(1.274) (1.219) (1.484) (1.376) 
  
High Risk $0  2.77 2.79 4.37 4.35 
  
  
(1.684) (1.515) (1.602) (1.45) 
  
 
$100  3.04 3.15 4.25 4.01 
  
  
(1.571) (1.393) (1.542) (1.57) 
  
            
  
        
WTP1: After reading the description, how willing would you be to participate in this 
study? 
        WTP2: How likely would other students like you be to participate in this study? 
        
 
1 - Not at all Willing / Likely; 6 - Very Willing / Likely 
 
 
        RiskP1: How concerned are you regarding the loss of the privacy of your personal 
information in this study? 
        RiskP2: How much risk to your privacy do you feel it is to have your DNA sample put in 
the repository being used for this study? 
        1 - Not at all Concerned / Risky; 6 - Very Concerned / Risky 
 
Table 5: Descriptive Statistics, M (SD), for Willingness to Participate and Risk Perception  
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 Hypothesis 2A: Main Effect of Risk on Risk Perception 
 Analyses of the main effects for of level of risk were examined for both risk perception 
measures following testing for interaction effects.  An analysis on the first risk perception 
measure (concern for privacy loss) showed a strong main effect of risk (F (1, 162) = 95.69, p < 
.01), with a large effect sizes at both the no compensation (d = 1.02, r = 0.46) and $100 
compensation (d = 0.8, r = 0.37) levels.  Similarly, analysis of the second risk perception 
measure (risk to privacy from DNA presented in a repository) showed a strong main effect of 
risk (F (1, 163) = 81.65, p < .01) with a large effect size at no compensation (d = 1.01, r = 0.45) 
level and a medium effect size at $100 compensation (d = 0.68, r = 0.32) level.  Both findings 
support the original hypothesis.  While the differences in effect sizes at the two levels of 
compensation seem to suggest that compensation is playing some role in perception of risk, the 
absence of an interaction effect may imply that any effect is so weak as to not be statistically 
significant.  The implications of this finding for ethical decisions will be discussed later. 
Hypothesis 2B: Main Effect of Money on Risk Perception 
 Separate analyses for main effects on each of the respective risk perception measures did 
not demonstrate a main effect of monetary compensation on either the first (F (1, 162) = .11, p = 
.74) or the second (F (1, 163) = .39, p = .54) risk perception measure.  Again as was found with 
analyses on willingness to participate, these findings do not support the original hypothesis that 
increased compensation would lead to decreased risk perception.  Viewed in conjunction with 
the absence of a main effect of monetary compensation in the willingness to participate self-
report item, the data seem to suggest that monetary compensation does not have a powerful 
effect on participants’ decisions to participate in genetic research studies, nor does it seem to 
influence their perception of the risks as presented to them.  However, given the lone main effect 
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of monetary compensation on the willingness to participate measure that asked participants for 
their perceptions of how willing others like them would be to participate, it would seem that 
current participants believe others will be more swayed by offers of money in genetic research 
than are the responding participants. 
WTP and Risk Perception with Research Attitudes Covariates 
 The Research Attitudes Questionnaire (RAQ) was given prior to presentation of the 
independent variable experimental stimuli (informed consents). Thus, these responses represent a 
priori perspectives on participants’ views of research.  Three RAQ questions were chosen for 
additional ANCOVA analyses with related dependent variables in order to determine if these 
pre-existing attitudes influenced the effects of the manipulation.  While the correlations between 
the dependent variables being examined and the RAQ measures were not significant in all cases 
(see Table 6), these additional analyses were used to explore the possibility that some error 
variance could be accounted for by means of RAQ score covariates, allowing the researchers to 
better determine if significant risk by money interaction effects are present for participants with 
certain pre-existing attitudes toward research. 
WTP with Importance of Money for Participation Covariate 
 A 2x2 mixed ANCOVA using the first willingness to participate measure (own 
willingness to participate) with the covariate (rating responses) from the RAQ item ‘When you 
consider whether to participate in a psychology research study, how important is the offer of 
being paid to participate in your decision?’ was conducted to assess for interaction effects of 
level of risk to loss of privacy and monetary compensation on willingness to participate.  The 
findings, as with previous analyses without the covariate, did not find any statistically significant 
level of risk by level of compensation interaction effect (F (1, 158) = 0.12, p = .73).  This  
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Table 6 : Correlations for Dependent Variables and RAQ 
 
         
Item 
WTP1     
(Low 
Risk) 
WTP1    
(High 
Risk) 
WTP2     
(Low 
Risk) 
WTP2    
(High 
Risk) 
RiskPerc1 
(Low 
Risk) 
RiskPerc1 
(High 
Risk) 
RiskPerc2 
(Low 
Risk) 
RiskPerc2  
(High 
Risk) 
# of Research 
Studies 
-.020 .015 .004 -.013 .005 .078 .067 .060 
# of 
Behavioral 
Genetics 
Studies 
-.008 .195* .038 .125 .165* .023 .187* -.018 
Enrolled 
Course 
-.067 .067 -.029 .099 .025 -.094 .044 -.038 
Previous 
Genetic 
Testing or 
Counseling 
-.099 -.048 -.193* -.101 -.108 .027 -.068 -.030 
Enjoy 
Research 
Participation 
.179* .132 .113 .092 -.021 .034 -.085 -.017 
Importance of 
Money for 
Participation 
-.139 .144 -.096 .147 .231** -.072 .251** -.078 
Value of 
Research to 
Education 
.044 .138 .155* .168* .166* .060 .104 -.052 
Seriousness of 
privacy loss 
-.067 -.114 -.045 -.038 .288** .256** .249** .264** 
Risk of 
Genetic 
Studies 
-.168* .098 -.069 .131 .290** .071 .353
** .204** 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
*. Correlation is significant at the 0.05 level (2-tailed). 
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analysis was also consistent with the main effect findings of previous analyses on this measure. 
In this analysis there was a significant risk main effect (F (1, 158) = 42.08, p < .01) but no main 
effect of money (F (1, 158) = 2.30, p = .13).  This finding suggests that pre-existing  
attitudes toward the importance of being paid for research participation do not affect 
participants’ strong consideration of risk and comparatively weak consideration of monetary 
compensation in their willingness to participate in behavioral genetics studies. 
Risk Perception with Seriousness of Loss of Privacy Covariate 
 A 2x2 mixed ANCOVA using the first risk perception measure (risk to loss of privacy) 
with the covariate (rating scores) of the RAQ item ‘How serious would it be if your privacy was 
violated as a result of participation in a research study?’ was conducted to assess for interaction 
effects of level of risk to loss of privacy and monetary compensation on perception of risk.  
These findings were again consistent with the original analyses, demonstrating no level of risk 
by level of compensation interaction effect (F (1, 161) = .01, p = .94), no main effect of money 
(F (1, 161) = .01, p = .99) and a main effect of risk (F (1, 161) = 5.54, p = .02).  This suggests 
that pre-existing attitudes about the seriousness of loss of privacy in a research study do not have 
a significant effect on how participants perceive risks to loss of privacy at different levels of risk 
and monetary compensation in behavioral genetic studies. 
Risk Perception with Risk of Genetic Studies Covariate 
 Finally, a 2x2 mixed ANCOVA using the first risk perception measure (risk to loss of 
privacy) with the covariate (rating scores) of the RAQ item ‘How risky, in your opinion, are 
studies in which genetic samples are taken?’ was conducted to assess for interaction effects of 
level of risk to loss of privacy and monetary compensation on perception of risk.  Consistent 
with all previous findings, the analysis showed no level of risk by level of compensation 
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interaction effect (F (1, 160) = 2.63, p = .11), main effect of money (F (1, 160) = .38, p = .54) 
and a main effect of risk (F (1, 160) = 23.81, p < .01).  Interestingly, there was a significant 
interaction between level of risk and the covariate, riskiness of genetic studies (F (1, 160) = 5.91, 
p = .02) which suggests that while pre-existing attitudes toward the riskiness of genetic studies in 
general has an effect on participants’ perception of the risks in the presented vignettes, it still 
does not demonstrate a differential effect of money on risk perception at different levels of risk 
or a statistically significant influence of money on risk perception.  All of these ANCOVA 
analyses had slightly varying N’s, which were affected by a few non-respondents to either the 
dependent variable measure or the RAQ item being used as a covariate in each category, though 
the absence of these non-respondents did not affect the overall distribution of scores in any of 
these cases. 
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CHAPTER 5 
DISCUSSION 
 This study was conducted to explore the separate and potential interactive influences of 
risk and money on participants’ perceptions of risk to loss of privacy and their willingness to 
participate in behavior genetic research. In addition the study was designed study was to extend 
the work of Ascheman (2009) in novel ways that were intended to clarify the influences on 
willingness to participate by exposure to a condition that did not involve money, the creation of a 
baseline risk condition, and by presentation of informed consent information through an 
alternative format, a story vignette. Prior studies that focused on research participants’ 
comprehension of informed consent documents (Ogloff & Otto, 1991; Hammerschmidt & 
Keane, 1992; Hochhauser, 1999; Sachs et al., 2003; Pedersen et al., 2011) indicated a low level 
of comprehension and recall of important points relevant to making an informed decision about 
research participation. A particular difficulty in several studies example has been extremely low 
comprehension of elements of the informed consent document.  For example, recent research by 
Pedersen et al. (2011) examined college students’ reading comprehension using both recall and 
recognition testing for significant elements of an informed consent document, but found that 
between 69% and 89% of participants across all conditions failed the comprehension checks.  
Previous research by Sachs et al. (2003) demonstrated even more broadly that the average 
healthy adult participant may not have a sufficient capacity to fully understand some informed 
consent documents.    
This study addressed the challenge of enhancing comprehension of the informed consent 
by using a novel informational procedure, presentation of all of the standard informed consent in 
a short vignette, rather than an IRB form format.  This approach appears to have borne fruit, with 
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between 78.8% and 80.5% of participants correctly identifying amounts of compensation being 
offered in the vignettes, 62.42% correctly identifying risks to loss of privacy and the ability of 
genetic data to be shared with people beyond the researchers in the high risk condition, and 
84.24% correctly identifying that their information would not be shared beyond the researchers 
in the low risk condition.  While only 43.2% of participants correctly identified the possibility of 
losing access to health, life or dental insurance if a pre-existing condition were identified from a 
contributed genetic sample in the high risk and no compensation treatment, this is a substantial 
improvement over the Ascheman’ study’s 14% overall comprehension rate and the informed 
consent comprehension rate of 11%-31% cited by Pedersen et al. (2011). 
Risk, Monetary Compensation, and Undue Inducement 
 The absence of any interaction effects between money and risk in all the measures of 
willingness to participate and risk perception suggests that money does not have a differential 
effect on how willing participants are to engage in behavioral genetic research at either low or 
high risk of loss to privacy of their genetic information in the context of this online study that 
involves hypothetical decision making.  Moreover, there was a consistent   absence of main 
effects of money on participants’ own willingness to participate or on any measure of their 
perceptions of risk.  This finding demonstrates how relatively small the effect of proposed 
monetary compensation is on urging participants to ignore risks posed by behavioral genetic 
research for the sake of getting paid to engage in a study. 
 The medium-to-large effects of risk to loss of privacy that were found for all willingness 
to participate and risk perception measures  demonstrates the  capacities of participants, when 
appropriate levels of comprehension and informed consent are present, to distinguish the levels 
of risk in behavioral genetics studies and accordingly adjust their willingness to engage in 
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participation. It appears that participants are able to distinguish risks and act in an appropriately 
informed manner without being unduly influenced by the amounts of compensation that were 
being offered in the vignettes of this study. 
Self-Perception of Influence of Money vs. Perception of Money’s Influence on Others 
 One particularly interesting finding is the significant main effect of money on the 
willingness to participate measure that asked participants to rate how likely others ‘like 
themselves’ would be to participate in the presented vignette studies.  This is made more 
interesting by the absence of a significant main effect on the willingness to participate measure 
looking at participants’ own willingness to participate in the vignette study.  The absence of this 
main effect also seems to be consistent with self-reports regarding the importance of money in 
the research attitudes questionnaire, which demonstrated a trend toward low concern about being 
paid for study participation (m = 2.45, sd = 1.04, N = 164). 
 This finding seems to suggest that participants believe that others, even others who are 
similar to themselves, are more easily influenced by money to participate in behavioral genetic 
research than are the participants.  The use of perception of risk as a measure instead of actual 
risk also leaves open the question: did participants perceive this study as a concrete exercise in a 
potential future risk or an abstract one in which they would not be expected to fully appreciate 
the level of risk.  The distinction between the results from the two willingness to participate 
variables appears to demonstrate that participants did not perceive this as an entirely abstract 
exercise, given that there was a significant difference between their own willingness to 
participate and their believe in others’ willingness to participate.  However, it may be helpful to 
additionally examine not just participants’ perception of others’ willingness to participate, but 
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their perception of the degree of risk others might experience from being involved in a 
behavioral genetic study. 
Informed Consent Comprehension 
 It has been thoroughly documented that informed consent processes are problematic and 
often demonstrate poor retention and recall of important elements of consent (Ogloff & Otto, 
1991; Hammerschmidt & Keane, 1992; Hochhauser, 1999; Sachs et al., 2003; Pedersen et al., 
2011).  This was again highlighted by the 14% comprehension rate of participants responding to 
questions about elements of risk and compensation in a manipulation of traditional informed 
consent documents in Ascheman (2009).  The present study focused on increasing through use of 
novel short vignettes that were carefully designed to contain the same elements of information 
present in traditional informed consent documents.  The vignette method used in this study to 
substantially increased comprehension rates for risks and compensation compares to Ascheman’s 
prior study. 
 Several long-standing areas of concern remain, however.  Higher risk conditions showed 
decreased comprehension rates relative to low risk conditions (62.42% in high risk compared to 
84.24% in low risk) when addressing potential loss of privacy of genetic data.  Many of the non-
comprehension responses in the high risk condition simply stated that there was no risk of loss to 
genetic privacy or that information wouldn’t be shared beyond the researchers of the presented 
study, which mirrored many of the responses in the low risk category that were, indeed, correct.  
This may mean that some of the ‘comprehending’ responses in the low risk condition were lucky 
guesses borne of a confidence that, as with most if not all other studies the participants had 
experienced through the university’s SONA research system, data access is always restricted to 
just the researchers for the current study. 
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 This concern is further highlighted by the comprehension question presented only to 
participants in the high risk and no compensation condition, “What are the risks associated with 
this study?”.  This question was purposefully selected only for the high risk and no compensation 
condition so that this study could assess whether or not participants were identifying the central 
manipulation of risk to loss of genetic privacy and the implications of this.  The high risk 
condition manipulation of the vignette read as: 
“After researchers have analyzed and digitally coded the genetic sample using the 
HiSeq 2000 genome sequencing machine, the coded data will be submitted and 
stored indefinitely with the participant’s name and unique personal code, linking 
the individual to the sample, into a national repository of genetic data that is 
accessible to other researchers, law enforcement agencies (including but not 
limited to local, state and federal law enforcement agencies), medical practitioners 
and medical, dental and life insurance companies.  As a result, if your genetic data 
shows a predisposition for serious health conditions (e.g., heart disease, diabetes, 
cancer) or serious mental illness (e.g., major depression, bipolar disorder, 
schizophrenia) you may be unable to receive health insurance in the future.” 
 The underlining in the above example was not added for emphasis for the sake of this 
manuscript, but rather was identical to what participants saw in the high risk conditions.  Despite 
this rather direct attempt at drawing attention to the serious potential risk of the inability to 
receive health insurance in the future if genetic data are submitted to this fictitious database, only 
43.2% of participants that viewed the high risk and no compensation vignette (N = 81) correctly 
identified this risk.  An additional 35.8% of these participants correctly identified the risk at the 
very bottom of the vignette, potential for some psychological discomfort from the questions and 
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a potential for a minor swelling reaction from buccal swabbing.  While many of those that 
correctly identified the risk of losing access to healthcare as laid out in the vignette also 
identified the psychological and cheek-swelling risks, the respondents that only identified this 
may have only been searching for the ‘correct’ answer and stopped after believing they had 
found it, which may also indicate they did not carefully read the vignette. 
 These findings are particularly unsettling given that if these participants had been in a 
real study such as this one, they may have unwittingly signed away their genetic privacy 
permanently.  Studies that do not have a comprehension check associated with their informed 
consent, whether that is a lab assistant asking questions or a written comprehension check that is 
examined by a researcher or assistant for comprehension, may have even lower rates of 
comprehension as these participants would not be primed to go back and read over at least part 
of the consent document.  It is important to note that if a participant does understand the risks 
associated with the permanent loss of their genetic privacy and consents to submit it regardless, 
that is entirely their decision and the researcher will have done their due diligence in the 
informed consent process.  However, in the current ‘sign here if you understand this document’ 
mode of collecting ‘informed’ consent documentation these problems may not surface until after 
a participant realizes what has happened, though in that case we are able to contend that they 
signed the document attesting that they understood what was happening.  The question then 
becomes who is ultimately responsible for informed consent; the participant or the researcher? 
Implications for Ethical Bodies 
 The findings of this study appear to validate the status quo of ethical decision making 
bodies such as institutional review boards.  The relatively large amount of money and the short 
amount of time necessary to contribute a genetic sample via buccal swabbing create what 
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Ascheman (2009) identified as a ‘large reward’ in a pilot study.  Even given this large reward, 
participants were not significantly swayed in either their willingness to participate or their 
perception of risk at either of the presented levels of risk.  Additionally, the finding of an effect 
of compensation on our perceptions of others’ willingness to participate would suggest that, if 
these ethical bodies are similarly susceptible to this effect, that ethical decision boards would 
likely be more hesitant to approve studies with large monetary inducements for concern that 
others would be more heavily influenced than they may actually be.  More research on this 
finding will need to be conducted before this assertion can be made, however. 
Limitations of the Study 
 One of the major limitations of this study is the manner in which the vignettes were 
presented to participants.  Since the vignettes were presented as studies that were pending 
approval from a university institutional review board, there was no immediate risk to participants 
if they stated that they would have been willing to participate in the study at a future date.  While 
the researchers attempted to help manage this limitation through the use of a social desirability 
scale to try and identify desirable responding, which in this case would be agreeing to being 
willing to participate if the studies were run and viewing them as not very risky, a study that 
could present these as real studies wherein participants would immediately have a sample taken 
might present different findings. 
 An additional limitation to the generalizability of this study is the short vignette format 
used for the manipulation.  While this technique appears to have generated substantially 
improved comprehension rates of the same elements that are present in traditional informed 
consent documents, the reality is that the traditional documents are what are actually being used 
in real behavioral genetics studies.  There is a demonstrable difference in comprehension 
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between this study’s vignettes and Ascheman’s (2009) traditional informed consent document 
manipulation, which also means that these same comprehension difficulties are more likely to be 
occurring in the field due to the more similar format Ascheman used. 
 The sample for this study was most representative of a Caucasian/European American 
population, and while it had higher than anticipated inclusion of persons from other ethnic 
backgrounds the findings may not be as readily generalizable to populations of college students 
where larger proportions of the population are not Caucasian.  The study also did not have a 
sufficient sample size to detect statistically significant small effects.  While this does not change 
the finding that monetary compensation does not appear to have a strong effect on willingness to 
participate or risk perception, particularly compared to the strong effects level of risk to loss of 
privacy appear to have, it may be helpful to identify if there is a significant but small main effect 
of money on these measures. 
 This study was completed entirely through the Qualtrics online data collection system, 
which means there was no control over the conditions in which participants completed the 
surveys presented.  As such, it is impossible to know if participants were consistently or 
intermittently attentive to the study’s measures, only whether or not they were able to 
comprehend the manipulations through the open-ended manipulation checks.  Response times 
were reported by the program, which indicated an overall mean response time of 36 minutes, 
though this is trimmed considerably to a mean response time of 15 minutes if outliers of four 
hours or greater are removed.  This study was also examining participants’ reactions to a 
hypothetical situation, and as such participants may have reacted differently in a more ‘real’ 
setting that presented immediate, direct consequences for decisions to participate.  Additionally, 
the SONA system allows potential participants to view the titles and descriptions of studies 
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before signing up, and as such there may be some participant self-selection along lines of 
individual interest taking place in the sample. 
Directions for Future Research 
 The findings of this study and the performance of the novel short-vignette format for 
informed consent information lead to several potential directions for future research.  One area 
that may be potentially useful for a wide variety of social science studies would be an 
examination of what allowed for such greatly improved comprehension using the short vignettes 
as opposed to more traditional consent documents.  The vignettes were selected for this study for 
their novelty compared to the traditional consent process, but if merely the novelty aids the 
increased comprehension then this would not be helpful for future studies as constantly changing 
the format of informed consent in research would be extremely impractical.  If, however, some 
other element or elements of the short-vignette format are contributing to increased 
comprehension, such as the abbreviated length or narrative format, then these could be simple 
but extremely beneficial in modifying the informed consent process to increase comprehension. 
 Further examination of the effects of risk to loss of privacy and monetary compensation 
in behavioral genetics studies may also prove useful.  In particular, a study that could maintain 
the core manipulations but modify the deceptive elements to have participants believe they 
would be consenting to giving a genetic sample immediately if they give consent may yield more 
powerful and generalizable results.  Coupling this with a larger sample size and ideally a more 
ethnically and geographically diverse population would also substantially increase the 
generalizability of the findings.  Additionally, examining a mediation model in which perceived 
risk acts as a mediator for willingness to participate in addition to the actual risk presented in the 
vignettes could yield substantial differences. 
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 Finally, more research on how we perceive how strongly others are affected by offers of 
monetary compensation in research studies beyond just behavioral genetic studies may prove 
helpful both to advance our understanding of how our perceptions of others’ ability to be 
influenced by differs from the actual amount of influence.  This research would not only further 
this understanding of our perceptions of others, but also help further inform ethical decision 
making bodies regarding what is considered undue inducement from a monetary standpoint. 
Conclusion 
 This study demonstrates that potential college student volunteer research participants in 
behavioral genetics studies take seriously the risks of participation in this line of research and are 
not powerfully swayed by promises of payment for their contribution. An institutional review 
board does its job of assessing risk and ensuring that these risks are appropriate to the study, are 
adequately described and that participants are informed before they give consent.  When this 
occurs this study paints a very positive picture of potential participants’ ability to make an 
informed decision.  
  A recurrent issue and ongoing challenge for this and all other studies dealing with risk in 
behavioral research is the continuing and documented low comprehension rates of informed 
consent documents.  Researchers and review boards can be as careful as possible to spell out all 
possible risks associated with a study, but if the information is presented in a format that is 
incomprehensible or is ignored by potential participants choosing to just sign on the dotted line 
then that work is futile.  The key to informed consent is the very concept of being ‘informed’, 
which leads once again to the question: who is responsible for making sure consent is informed? 
 Given the size and sheer volume of social science research occurring at institutions 
around the world, it would likely be impractical to quiz every individual participating in research 
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over the details of an informed consent document.  In many cases, the likelihood of harm coming 
to a social science participant who hasn’t been fully informed by the consent process is very low, 
a protective consequence of the institutional review process necessary to conduct research.  
However, finding different ways to convey to an inform potential participants about varying 
levels of risk and the direct consequences to them from participation in social science research 
may become more important than ever now that collaborative medical, neuroscience and 
psychology investigations are becoming more frequent. 
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APPENDIX A – STUDY FLOWCHART 
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APPENDIX B – COMPREHENSION CHECK QUESTOINNAIRE 
 
Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
 
 
3) [High Risk, $0 condition only] What are the risks associated with this study? 
 
________________________________________________________________ 
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APPENDIX C – VIGNETTE QUESTIONNAIRE 
 
1. (Willingness to Participate) After reading the description, how willing would you be to 
participate in this study? 
2. (Willingness to Participate) How likely would other students like you be to participate in this 
study? 
3. (Risk Perception) How concerned are you regarding the loss of the privacy of your personal 
information in this study? 
4. (Risk Perception) How much risk to your privacy do you feel it is to have your DNA sample 
put in the repository being used for this study? 
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APPENDIX D – FACTOR ANALYSIS OF ASCHEMAN’S (2009)  
RISK AND WILLINGNESS SCALES 
 
Rotated Component Matrix(a) 
  
 
  Factor  
  1 2 
*PRIVDNA 145) How much 
risk to your privacy do you 
feel it is to have your DNA 
sample put in a repository? 
.857 -.034 
*LOSS144) How concerned 
are you regarding the loss 
of the privacy of your 
personal information in this 
study? 
.763 -.161 
*PROB 146) What is the 
probability that your 
personal information would 
be used unethically and in 
a way inconsistent with the 
wording of the informed 
consent? 
.714 -.048 
*SERIOUS 147) How 
serious would the negative 
consequences related to 
loss of privacy be if they 
occurred? 
.545 -.045 
*WTP 141) After reading 
the informed consent, but 
before participating, how 
willing were you to 
participate in this study? 
-.215 .945 
*OTHERS 142) How likely 
would other students like 
you be to participate in this 
study? 
-.185 .714 
*ENJOY 148)  How much 
did you enjoy participating 
in this research study? 
-.093 .487 
*$IMPORTANT 143) How 
important was the amount 
of compensation in your 
decision to participate? 
.110 .319 
Extraction Method: Principal Axis Factoring.  
 Rotation Method: Varimax with Kaiser Normalization. 
a  Rotation converged in 3 iterations. 
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APPENDIX E – RISK AND WILLINGNESS MEASURE CORRELATIONS 
 
 Descriptive Statistics 
 
  Mean Std. Deviation N 
RISK 10.2143 3.84265 182 
WILLING 12.0055 3.53279 182 
 
 Correlations 
 
    ZB_RISK ZB_WILLING 
RISK Pearson Correlation 1 -.187(*) 
  Sig. (2-tailed)   .011 
  N 182 182 
WILLING Pearson Correlation -.187(*) 1 
  Sig. (2-tailed) .011   
  N 182 182 
*  Correlation is significant at the 0.05 level (2-tailed). 
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APPENDIX F – RISK AND WILLINGNESS MEASURE RELIABILITY 
 Reliability Statistics 
 
Cronbach's 
Alpha N of Items 
.759 3 
 
 Item Statistics 
 
  Mean Std. Deviation N 
*WTP 141) After reading 
the informed consent, but 
before participating, how 
willing were you to 
participate in this study? 
3.26 1.373 182 
*OTHERS 142) How likely 
would other students like 
you be to participate in this 
study? 
3.34 1.005 182 
*ENJOY 148)  How much 
did you enjoy participating 
in this research study? 
2.54 1.065 182 
 
 Item-Total Statistics 
 
  
Scale Mean if 
Item Deleted 
Scale 
Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
*WTP 141) After reading 
the informed consent, but 
before participating, how 
willing were you to 
participate in this study? 
5.88 2.891 .724 .517 
*OTHERS 142) How likely 
would other students like 
you be to participate in this 
study? 
5.80 4.369 .661 .618 
*ENJOY 148)  How much 
did you enjoy participating 
in this research study? 
6.60 4.926 .444 .824 
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APPENDIX F (Cont.) – RISK AND WILLINGNESS MEASURES RELIABILITY
 Reliability Statistics 
 
Cronbach's 
Alpha N of Items 
.804 4 
 Item Statistics 
  Mean Std. Deviation N 
*LOSS144) How concerned 
are you regarding the loss 
of the privacy of your 
personal information in this 
study? 
2.46 1.303 182 
*PRIVDNA 145) How much 
risk to your privacy do you 
feel it is to have your DNA 
sample put in a repository? 
2.60 1.278 182 
*PROB 146) What is the 
probability that your 
personal information would 
be used unethically and in 
a way inconsistent with the 
wording of the informed 
consent? 
2.13 .937 182 
*SERIOUS 147) How 
serious would the negative 
consequences related to 
loss of privacy be if they 
occurred? 
3.03 1.285 182 
 Item-Total Statistics 
  
Scale Mean if 
Item Deleted 
Scale 
Variance if 
Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
*LOSS144) How concerned 
are you regarding the loss 
of the privacy of your 
personal information in this 
study? 
7.76 8.151 .661 .734 
*PRIVDNA 145) How much 
risk to your privacy do you 
feel it is to have your DNA 
sample put in a repository? 
7.62 7.862 .735 .694 
*PROB 146) What is the 
probability that your 
personal information would 
be used unethically and in 
a way inconsistent with the 
wording of the informed 
consent? 
8.08 10.142 .628 .763 
*SERIOUS 147) How 
serious would the negative 
consequences related to 
loss of privacy be if they 
occurred? 
7.19 9.236 .497 .817 
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APPENDIX G – INSTITUTIONAL REVIEW BOARD APPROVAL 
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APPENDIX H – MARLOWE-CROWNE 10-ITEM SOCIAL DESIRABILITY SCALE 
 
Listed below are a number of statements concerning personal attitudes and traits. Read each item 
and decide whether the statement is true or false as it pertains to you personally. 
1) I am always willing to admit it when I make a mistake 
2) I always try to practice what I preach. 
3) I never resent being asked to return a favor. 
4) I have never been irritated when people expressed ideas very different from my own. 
5) I have never deliberately said something that hurt someone's feelings. 
6) *I like to gossip at times. 
7) *There have been occasions when I took advantage of someone. 
8) *I sometimes try to get even rather than forgive and forget. 
9) *At times I have really insisted on having things my own way. 
10) *There have been occasions when I felt like smashing things. 
*Items are reverse-coded 
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APPENDIX I – IPIP NEO PERSONALITY SCALE 
In the following section, there are phrases describing behaviors. Please use the rating scale 
below to describe how accurately each statement describes you. Describe yourself as you 
generally are now, not as you wish to be in the future. 
 
Very         Moderately Neither Inaccurate      Moderately  Very 
Inaccurate       Inaccurate  Nor Accurate       Accurate  Accurate 
     1     2   3   4       5 
 
1. Feel comfortable around people. 
2. Have frequent mood swings. 
3. Believe that others have good intentions. 
4. Don't see things through. 
5. Tend to vote for conservative political candidates. 
6. Waste my time. 
7. Suspect hidden motives in others. 
8. Carry out my plans. 
9. Am always prepared. 
10. Respect others. 
11. Am very pleased with myself. 
12. Tend to vote for liberal political candidates. 
13. Am skilled in handling social situations. 
14. Don't like to draw attention to myself. 
15. Feel comfortable with myself. 
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16. Am the life of the party. 
17. Seldom feel blue. 
18. Find it difficult to get down to work. 
19. Insult people. 
20. Don't talk a lot. 
21. Panic easily. 
22. Have a good word for everyone. 
23. Am not easily bothered by things. 
24. Do just enough work to get by. 
25. Get back at others. 
26. Have little to say. 
27. Have a sharp tongue. 
28. Make plans and stick to them. 
29. Rarely get irritated. 
30. Keep in the background. 
31. Carry the conversation to a higher level. 
32. Do not like art. 
33. Accept people as they are. 
34. Enjoy hearing new ideas. 
35. Would describe my experiences as somewhat dull. 
36. Believe in the importance of art. 
37. Am often down in the dumps. 
38. Avoid my duties. 
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39. Make people feel at ease. 
40. Get chores done right away. 
41. Avoid philosophical discussions. 
42. Often feel blue. 
43. Make friends easily. 
44. Have a vivid imagination. 
45. Pay attention to details. 
46. Cut others to pieces. 
47. Know how to captivate people. 
48. Dislike myself. 
49. Am not interested in abstract ideas. 
50. Do not enjoy going to art museums. 
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APPENDIX J – IPIP NEO ITEM POOL 
NEUROTICISM - 10-item scale (Alpha = .86) 
+ keyed  
 Often feel blue. 
 Dislike myself. 
 Am often down in the dumps. 
 Have frequent mood swings. 
 Panic easily. 
– keyed 
 Rarely get irritated. 
 Seldom feel blue. 
 Feel comfortable with myself. 
 Am not easily bothered by things. 
 Am very pleased with myself. 
EXTROVERSION - 10-item scale (Alpha = .86) 
+ keyed  
 Feel comfortable around people. 
 Make friends easily. 
 Am skilled in handling social situations. 
 Am the life of the party. 
 Know how to captivate people. 
– keyed 
 Have little to say. 
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 Keep in the background. 
 Would describe my experiences as somewhat dull. 
 Don't like to draw attention to myself. 
 Don't talk a lot. 
OPENNESS TO EXPERIENCE - 10-item scale (Alpha = .82) 
+ keyed 
 Believe in the importance of art. 
 Have a vivid imagination. 
 Tend to vote for liberal political candidates. 
 Carry the conversation to a higher level. 
 Enjoy hearing new ideas. 
– keyed 
 Am not interested in abstract ideas. 
 Do not like art. 
 Avoid philosophical discussions. 
 Do not enjoy going to art museums. 
 Tend to vote for conservative political candidates. 
AGREEABLENESS - 10-item scale (Alpha = .77) 
+ keyed  
 Have a good word for everyone. 
 Believe that others have good intentions. 
 Respect others. 
 Accept people as they are. 
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 Make people feel at ease. 
– keyed 
 Have a sharp tongue. 
 Cut others to pieces. 
 Suspect hidden motives in others. 
 Get back at others. 
 Insult people. 
CONSCIENTIOUSNESS - 10-item scale (Alpha = .81) 
+ keyed 
 Am always prepared. 
 Pay attention to details. 
 Get chores done right away. 
 Carry out my plans. 
 Make plans and stick to them. 
– keyed 
 Waste my time. 
 Find it difficult to get down to work. 
 Do just enough work to get by. 
 Don't see things through. 
 Shirk my duties. 
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APPENDIX K – SAMPLE VIGNETTE 
Instructions: 
 Your opinions and reactions as a Psychology student provide a unique perspective that is 
essential to a complete understanding of student perceptions of upcoming research.  The 
following studies are currently being planned to potentially begin data collection [next 
semester].  As part of the review procedure it is vital that the input of students be considered in 
addition to experts in the relevant fields, as students will make up the majority of the individuals 
being sampled in these studies.  Please read the overview of each study carefully and completely, 
as some of the language used may be similar but important details may vary.  After reading the 
description each study please take a moment to fully and honestly complete the brief attached 
questionnaire.  Thank you in advance for your participation. By completing this study you will be 
giving reviewers important insight into the opinions of students who may potentially participate 
in these studies. 
Study Title: Genetic Variation in Genome P36 and Subjective Well-Being 
Description: This study will be investigating how variations in the P36 Genome potentially 
affect measures of subjective well-being.  Participation in this study is completely voluntary and 
those who choose to participate may withdraw at any time with no penalty.  The study should 
take approximately 50 minutes to complete.  Participants in this study will be asked to complete 
a brief well-being questionnaire, after which they will contribute a genetic sample by means of 
buccal (cheek) swabbing.  After researchers have analyzed and digitally coded the genetic 
sample using the HiSeq 2000 genome sequencing machine, the coded data will be  
[Low Risk: stripped of identifiers, leaving no name or code linking the sample to the 
participant, before being entered into a secure encrypted and password protected 
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electronic file database accessible only by the research team and will be destroyed after 
two years; High Risk: submitted and stored indefinitely with the participant's unique 
personal code, linking the individual to the sample, into a national repository of genetic 
data that is accessible to other researchers, law enforcement agencies (including but not 
limited to local, state and federal law enforcement agencies), medical practitioners and 
medical, dental and life insurance companies.  As a result, if your genetic data shows a 
predisposition for serious health conditions, you may be unable to receive health 
insurance in the future].   
Researchers will then use this data in conjunction with the self-report questionnaire in hopes of 
determining if there is a genetic link between subjective well-being and the P36 Genome.  As 
benefits, participants will receive  
[No Compensation: no money for their genetic contribution, but will gain firsthand 
knowledge of how genetic research is conducted; High Compensation: $100 for their 
genetic contribution, and will gain firsthand knowledge of how genetic research is 
conducted.]  
Potential risks during the study include a minor swelling reaction to the buccal swab and 
potential psychological discomfort from the presented questionnaires. 
 
Questions or information requests regarding this study should be directed to the experimenters in 
charge of the review study, Zachary Batchelder at zacharyb@iastate.edu or Norman Scott at 
nascott@iastate.edu.  If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB administrator, (515) 294-4566, irb@iastate.edu, or 
Director, (515) 294-3115, Office for Responsible Research, Iowa State University, Ames, Iowa 
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Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
 
 
3) [High Risk, $0 condition only] What are the risks associated with this study? 
___________________________________________________________________ 
 
 
Please rate your responses to the following questions about this study using the scoring system 
provided: 
1. After reading the description, how willing would you be to participate in this study? 
Not At All Willing              Very Willing 
1  2  3  4  5  6  
2. How likely would students who are similar to you be to participate in this study? 
Not At All Likely              Very Likely 
 1  2  3  4  5  6  
3. How concerned are you regarding the loss of the privacy of your personal information in this 
study? 
Not At All Concerned              Very Concerned 
 1  2  3  4  5  6  
4. How much risk to your privacy do you feel it is to have your DNA sample put in the database 
being used for this study? 
Not At All Risky              Very Risky 
1  2  3  4  5  6 
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APPENDIX L – RESEARCH ATTITUDES QUESTIONNAIRE 
1) For you, what is the most important factor in deciding whether or not to participate in a 
psychology research study? 
________________________________________________________________________ 
________________________________________________________________________ 
2) How many research studies have you participated in? 
a) 0 
b) 1-2 
c) 3-4 
d) 5-6 
e) 7 or more 
3) In how many behavioral genetics studies have you been a participant? 
a) 0 
b) 1-2 
c) 3-4 
d) 5-6 
e) 7 or more 
4) Which course will be receiving credit in for completing this study? 
a) Psychology 101 
b) Psychology 230 
c) Psychology 380 
d) Communication Studies 101 
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5) Have you ever undergone medically related genetic testing or genetic counseling? 
a) Yes 
b) No 
6) How much do you enjoy participating in research studies? 
 Not At All                        Some        Very Much 
  1  2  3  4  5 
7) When you consider whether to participate in a psychology research study, how important 
is the offer of being paid to participate in your decision? 
 Not Important            Somewhat Important  Very Important 
  1  2  3  4  5 
8) How valuable did you find participating in psychology research studies in furthering your 
education? 
 Not Valuable            Somewhat Valuable  Very Valuable 
  1  2  3  4  5 
9) How serious would it be if your privacy was violated as a result of participation in a 
research study? 
 Not Very Serious  Somewhat Serious      Very Serious 
  1  2  3  4  5 
10) How risky, in your opinion, are studies in which genetic samples are taken? 
      Not Risky           Somewhat Risky      Very Risky 
  1  2  3  4  5 
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APPENDIX M – RESEARCH ATTITUDES WRITING TASK 
Please thoughtfully answer the following question in a few short sentences: 
What do you think are the advantages and risks associated with scientific research on genetics? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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APPENDIX N – SONA POSTING FORM 
STUDY POSTING FORM 
 
 
PRINCIPAL INVESTIGATOR (Faculty Supervisor): Norman Scott 
RESEARCHERS: Zachary Batchelder 
 
STUDY NAME & NUMBER: Undergraduate Perceptions of Genetic Research 
 
BRIEF ABSTRACT: 
 
This study is looking to gather psychology student views on behavioral genetics research projects that are 
currently pending approval.  Online survey, maximum 50 minutes, 1 research credit for participation. 
 
STUDY DESCRIPTION (Must be exactly as approved by IRB):  
 
The purpose of this anonymous online study is to examine undergraduate students’ perceptions of planned 
behavioral genetics studies at Iowa State University. You are being invited to participate in this study 
because you are an undergraduate student (age 18+) enrolled in a qualifying course.   
 
If you agree to participate in this study, your participation will last for approximately fifty minutes. During 
the study, you may expect the following study procedures to be followed: You will be asked to complete an 
online survey about your perceptions of research projects that are pending approval. While we would like 
you to complete all the items, during your participation, you may skip any question that you do not wish to 
answer or that makes you feel uncomfortable. 
 
 
ELIGIBILITY REQUIREMENTS: 
 
DURATION (Minimum 50min.): 50 minutes 
 
CREDITS: 1 credit 
 
PREPARATION: 
 
IRB APPROVAL CODE: 
 
IRB APPROVAL EXPIRATION: 
 
IS THIS AN ONLINE STUDY?  Yes 
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APPENDIX O – WEB-BASED INFORMED CONSENT DOCUMENT 
INFORMED CONSENT DOCUMENT 
 
Title of Study:  Undergraduate Perceptions of Genetic Research 
Investigators:   Zachary R Batchelder, B.S.   
   Norman Scott, Ph.D.  
 
This anonymous online research study that will take less than 50 minutes to complete.  Please 
take your time in deciding if you would like to participate.  Please feel free to ask questions at 
any time. You must be 18 years old to participate in this study. As indicated in your psychology 
course syllabus, participation in research studies is one option for earning experimental credit. 
 
INTRODUCTION 
The purpose of this study is to examine undergraduate students’ perceptions of proposed 
behavioral genetics studies at Iowa State University. You are being invited to participate in this 
study because you are an undergraduate student (age 18+) enrolled in a qualifying course.   
 
DESCRIPTION OF PROCEDURES 
If you agree to participate in this study, your participation will last for approximately fifty 
minutes. During the study, you may expect the following study procedures to be followed: You 
will be asked to complete an online survey about your perceptions of research projects that are 
being planned. While we would like you to complete all the items, during your participation, you 
may skip any question that you do not wish to answer or that makes you feel uncomfortable.  
 
RISKS  
While participating in this study, you may experience the following risks: some mild personal 
discomfort when you respond to personal questions about yourself or your perceptions of 
research studies. Most often, however, students do not find these questions to be too personal or 
too difficult.  
 
BENEFITS 
If you decide to participate in this study there will be no direct benefit to you. It is hoped that the 
information gained in this study will benefit society by providing valuable information about 
how undergraduate students perceive and react to behavioral genetics research. 
 
COSTS AND COMPENSATION 
You will not have any costs from participating in this study. You will be compensated for 
participating in this study (approx. 50 minutes) with one research credit toward your ComSt 101, 
Psych 101, Psych 230, or Psych 280 class(es) consistent with the Psychology Department 
guidelines. 
 
PARTICIPANT RIGHTS 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time. If you decide to not participate in the study or leave the study early, 
it will not result in any penalty or loss of benefits to which you are otherwise entitled.  
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CONFIDENTIALITY 
Records identifying participants will be kept confidential to the extent permitted by applicable 
laws and regulations and will not be made publicly available. However, federal government 
regulatory agencies, auditing departments of Iowa State University, and the Institutional Review 
Board (a committee that reviews and approves human subject research studies) may inspect 
and/or copy your records for quality assurance and data analysis. These records may contain 
private information.   To ensure confidentiality to the extent permitted by law, the following 
measures will be taken: All data will be collected anonymously. An arbitrarily assigned numeric 
code will be used on all forms instead of name. Data files will be kept for no longer than five 
years and will be destroyed at the end of this period. Electronic data will be stored on the 
investigators’ computers in password protected computer files accessible only by the 
investigators. If the results are published, only aggregate group data, not individual responses, 
will be reported. Your anonymity will be assured. 
 
QUESTIONS OR PROBLEMS 
You are encouraged to ask questions at any time during this study. For further information about 
the study contact Zachary Batchelder: zacharyb@iastate.edu or Norman Scott: 
nascott@iastate.edu. If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB Administrator, (515) 294-4566, IRB@iastate.edu, or 
Director, (515) 294-3115, Office of Responsible Research, Iowa State University, Ames, Iowa 
50011.   
***************************************************************************  
 
PARTICIPANT SIGNATURE 
Your digital confirmation, by responding yes or no to the following question, indicates that you 
voluntarily agree to participate in this study, that the study has been explained to you, that you 
have been given the time to read the document and that your questions have been satisfactorily 
answered. Please print a copy of this informed consent document for you records. 
 
Do you wish to participate in this study after you have having read this form and understood 
what is being asked? 
 
1-Yes 
2-No  
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APPENDIX P – DEMOGRAPHICS QUESTIONNAIRE 
Please answer the following questions: 
1) What is your age? 
 a) 18-20 
 b) 21-22 
 c) 23-24 
 d) 25-26 
e) 27 or older 
2) What is your school classification? 
 a) Freshman 
 b) Sophomore 
 c) Junior 
 d) Senior 
 e) Graduate or Other 
3) What is your major? 
 a) open response 
4) What is your primary race/ethnicity? 
 a) Caucasian / European American 
 b) Black / African American 
 c) Hispanic / Latino/a 
 d) Hawaiian / Pacific Islander 
 e) Asian / Asian American 
 f) American Indian / Native Alaskan 
 g) Multiracial 
 h) Other 
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APPENDIX Q – DEBRIEFING STATEMENT 
 Thank you for your participation. I want to reassure you that all your responses are 
confidential and will be combined with the responses of other participants to protect your 
identity.  Before exiting this survey, we would like to tell you more about the research project.  
We ask that you not share the information with others who might participate in our study in the 
future.  If a participant knew the study’s purpose before participating, their data would be invalid 
and our findings would be invalid as a result. 
 The true purpose of this study was not to examine students' views of potential genetic 
studies but rather to examine students' concern about their genetic privacy and the influence of 
money on the decision to participate in research that includes a risk to genetic privacy.  In order 
to accurately evaluate students’ level of concern, it was necessary to disguise the true purpose of 
the study.  Each of the studies presented during this survey were purposefully designed studies 
created by the researchers to vary only on how great the risk to participants' genetic privacy was 
and how much money would be given to participants. 
 The findings of this research have the potential to provide important insights into the 
influence of money on perception of risk, which, in turn, may suggest strategies and 
interventions that could benefit society at large. We did not tell you this information before 
because knowing the true purpose of the study could lead participants to consciously or 
unconsciously alter their responses.  If that were to occur, the integrity of the research findings 
would be compromised.  Again, for the integrity of this study, we ask that you not discuss these 
elements with other students. 
 If you do not want your response data to be used in our research, you may request that it 
be destroyed by emailing the primary investigator at (zacharyb@iastate.edu). However, due to 
the anonymous nature of your responses, you must make this request immediately following the 
debriefing so that your completion time can be associated with the otherwise anonymous data. 
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APPENDIX R – INFORMATIONAL PAMPHLET 
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APPENDIX R (Cont.) – INFORMATIONAL PAMPHLET 
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APPENDIX S – FULL VIGNETTES FOR ALL CONDITIONS 
Instructions: 
 Your opinions and reactions as a Psychology student provide a unique perspective that is 
essential to a complete understanding of student perceptions of upcoming research.  The 
following studies are currently being planned to potentially begin data collection in the Fall 
2012 semester.  As part of the review procedure it is vital that the input of students be considered 
in addition to experts in the relevant fields, as students will make up the majority of the 
individuals being sampled in these studies.  Please read the overview of each study carefully and 
completely, as some of the language used may be similar but important details may vary.  After 
reading the description each study please take a moment to fully and honestly complete the brief 
attached questionnaire.  Thank you in advance for your participation. By completing this study 
you will be giving reviewers important insight into the opinions of students who may potentially 
participate in these studies. 
 
Study Title: [Low Risk x $0] Genetic Variation in Genome CD4 and Subjective Well-Being  
Description: This study will be investigating how variations in the P36 Genome potentially 
affect measures of subjective well-being.  Participation in this study is completely voluntary and 
those who choose to participate may withdraw at any time with no penalty.  The study should 
take approximately 50 minutes to complete.  Participants in this study will be asked to complete 
a brief well-being questionnaire, after which they will contribute a genetic sample by means of 
buccal (cheek) swabbing.  After researchers have analyzed and digitally coded the genetic 
sample using the HiSeq 2000 genome sequencing machine, the coded data will be stripped of 
identifiers, leaving no name or code linking the sample to the participant, before being entered 
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into a secure encrypted and password protected electronic file database accessible only by the 
research team and will be destroyed after two years.  Researchers will then use this data in 
conjunction with the self-report questionnaire in hopes of determining if there is a genetic link 
between subjective well-being and the P36 Genome.  As benefits, participants will receive no 
money for their genetic contribution, but will gain firsthand knowledge of how genetic research 
is conducted.  Potential risks during the study include a minor swelling reaction to the buccal 
swab and potential psychological discomfort from the presented questionnaires. 
 
Questions or information requests regarding this study should be directed to the experimenters in 
charge of the review study, Zachary Batchelder at zacharyb@iastate.edu or Norman Scott at 
nascott@iastate.edu.  If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB administrator, (515) 294-4566, irb@iastate.edu, or 
Director, (515) 294-3115, Office for Responsible Research, Iowa State University, Ames, Iowa 
50011. 
 
Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
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Please rate your responses to the following questions about this study using the scoring system 
provided: 
1. After reading the description, how willing would you be to participate in this study? 
Not At All Willing              Very Willing 
1  2  3  4  5  6  
2. How likely would students who are similar to you be to participate in this study? 
Not At All Likely              Very Likely 
 1  2  3  4  5  6  
3. How concerned are you regarding the loss of the privacy of your personal information in this 
study? 
Not At All Concerned              Very Concerned 
 1  2  3  4  5  6  
4. How much risk to your privacy do you feel it is to have your DNA sample put in the database 
being used for this study? 
Not At All Risky              Very Risky 
1  2  3  4  5  6  
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Instructions: 
 Your opinions and reactions as a Psychology student provide a unique perspective that is 
essential to a complete understanding of student perceptions of upcoming research.  The 
following studies are currently being planned to potentially begin data collection in the Fall 
2012 semester.  As part of the review procedure it is vital that the input of students be considered 
in addition to experts in the relevant fields, as students will make up the majority of the 
individuals being sampled in these studies.  Please read the overview of each study carefully and 
completely, as some of the language used may be similar but important details may vary.  After 
reading the description each study please take a moment to fully and honestly complete the brief 
attached questionnaire.  Thank you in advance for your participation. By completing this study 
you will be giving reviewers important insight into the opinions of students who may potentially 
participate in these studies. 
 
Study Title: [Low Risk x $100] Role of the IL2 Gene in Self-Esteem  
Description: This study will be investigating whether the IL2 gene has an increased prevalence 
in individuals with higher self-esteem.  Participation in this study is completely voluntary and 
those who choose to participate may withdraw at any time with no penalty.  The study should 
take approximately 50 minutes to complete.  Participants in this study will be asked to complete 
a brief self-esteem questionnaire, after which they will contribute a genetic sample by means of 
buccal (cheek) swabbing.  After researchers have analyzed and digitally coded the genetic 
sample using the HiSeq 2000 genome sequencing machine, the coded data will be stripped of 
identifiers, leaving no name or code linking the sample to the participant, before being entered 
into a secure encrypted and password protected electronic file database accessible only by the 
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research team and will be destroyed after two years.  Researchers will then use this data in 
conjunction with the self-report questionnaire in hopes of determining if there is a genetic link 
between subjective well-being and the P36 Genome.  As benefits, participants will receive $100 
for their genetic contribution, and will gain firsthand knowledge of how genetic research is 
conducted.  Potential risks during the study include a minor swelling reaction to the buccal swab 
and potential psychological discomfort from the presented questionnaires. 
 
Questions or information requests regarding this study should be directed to the experimenters in 
charge of the review study, Zachary Batchelder at zacharyb@iastate.edu or Norman Scott at 
nascott@iastate.edu.  If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB administrator, (515) 294-4566, irb@iastate.edu, or 
Director, (515) 294-3115, Office for Responsible Research, Iowa State University, Ames, Iowa 
50011. 
 
Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
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Please rate your responses to the following questions about this study using the scoring system 
provided: 
1. After reading the description, how willing would you be to participate in this study? 
Not At All Willing              Very Willing 
1  2  3  4  5  6  
2. How likely would students who are similar to you be to participate in this study? 
Not At All Likely              Very Likely 
 1  2  3  4  5  6  
3. How concerned are you regarding the loss of the privacy of your personal information in this 
study? 
Not At All Concerned              Very Concerned 
 1  2  3  4  5  6  
4. How much risk to your privacy do you feel it is to have your DNA sample put in the database 
being used for this study? 
Not At All Risky              Very Risky 
1  2  3  4  5  6  
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Instructions: 
 Your opinions and reactions as a Psychology student provide a unique perspective that is 
essential to a complete understanding of student perceptions of upcoming research.  The 
following studies are currently being planned to potentially begin data collection in the Fall 
2012 semester.  As part of the review procedure it is vital that the input of students be considered 
in addition to experts in the relevant fields, as students will make up the majority of the 
individuals being sampled in these studies.  Please read the overview of each study carefully and 
completely, as some of the language used may be similar but important details may vary.  After 
reading the description each study please take a moment to fully and honestly complete the brief 
attached questionnaire.  Thank you in advance for your participation. By completing this study 
you will be giving reviewers important insight into the opinions of students who may potentially 
participate in these studies. 
 
Study Title: [High Risk x $0] Effects of MCM6 on Exercise Habits  
Description: This study will be investigating how the presence or absence of gene MCM6 
affects exercise habits.  Participation in this study is completely voluntary and those who choose 
to participate may withdraw at any time with no penalty.  The study should take approximately 
50 minutes to complete.  Participants in this study will be asked to complete a brief exercise 
habits questionnaire, after which they will contribute a genetic sample by means of buccal 
(cheek) swabbing.  After researchers have analyzed and digitally coded the genetic sample using 
the HiSeq 2000 genome sequencing machine, the coded data will be submitted and stored 
indefinitely with the participant's unique personal code, linking the individual to the sample, into 
a national repository of genetic data that is accessible to other researchers, law enforcement 
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agencies (including but not limited to local, state and federal law enforcement agencies), medical 
practitioners and medical, dental and life insurance companies.  As a result, if your genetic data 
shows a predisposition for serious health conditions, you may be unable to receive health 
insurance in the future.  Researchers will then use this data in conjunction with the self-report 
questionnaire in hopes of determining if there is a genetic link between subjective well-being and 
the P36 Genome.  As benefits, participants will receive no money for their genetic contribution, 
but will gain firsthand knowledge of how genetic research is conducted.  Potential risks during 
the study include a minor swelling reaction to the buccal swab and potential psychological 
discomfort from the presented questionnaires. 
 
Questions or information requests regarding this study should be directed to the experimenters in 
charge of the review study, Zachary Batchelder at zacharyb@iastate.edu or Norman Scott at 
nascott@iastate.edu.  If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB administrator, (515) 294-4566, irb@iastate.edu, or 
Director, (515) 294-3115, Office for Responsible Research, Iowa State University, Ames, Iowa 
50011. 
 
Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
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3) What are the risks associated with this study? 
___________________________________________________________________ 
 
 
Please rate your responses to the following questions about this study using the scoring system 
provided: 
1. After reading the description, how willing would you be to participate in this study? 
Not At All Willing              Very Willing 
1  2  3  4  5  6  
2. How likely would students who are similar to you be to participate in this study? 
Not At All Likely              Very Likely 
 1  2  3  4  5  6  
3. How concerned are you regarding the loss of the privacy of your personal information in this 
study? 
Not At All Concerned              Very Concerned 
 1  2  3  4  5  6  
4. How much risk to your privacy do you feel it is to have your DNA sample put in the database 
being used for this study? 
Not At All Risky              Very Risky 
1  2  3  4  5  6  
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Instructions: 
 Your opinions and reactions as a Psychology student provide a unique perspective that is 
essential to a complete understanding of student perceptions of upcoming research.  The 
following studies are currently being planned to potentially begin data collection in the Fall 
2012 semester.  As part of the review procedure it is vital that the input of students be considered 
in addition to experts in the relevant fields, as students will make up the majority of the 
individuals being sampled in these studies.  Please read the overview of each study carefully and 
completely, as some of the language used may be similar but important details may vary.  After 
reading the description each study please take a moment to fully and honestly complete the brief 
attached questionnaire.  Thank you in advance for your participation. By completing this study 
you will be giving reviewers important insight into the opinions of students who may potentially 
participate in these studies. 
 
Study Title: [High Risk x $100] CCR5’s Correlation to Openness to New Experience  
Description: This study will be investigating how presence or absence of the CCR5 gene 
correlates with participants’ openness to new experiences.  Participation in this study is 
completely voluntary and those who choose to participate may withdraw at any time with no 
penalty.  The study should take approximately 50 minutes to complete.  Participants in this study 
will be asked to complete a brief personality traits questionnaire, after which they will contribute 
a genetic sample by means of buccal (cheek) swabbing.  After researchers have analyzed and 
digitally coded the genetic sample using the HiSeq 2000 genome sequencing machine, the coded 
data will be submitted and stored indefinitely with the participant's unique personal code, linking 
the individual to the sample, into a national repository of genetic data that is accessible to other 
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researchers, law enforcement agencies (including but not limited to local, state and federal law 
enforcement agencies), medical practitioners and medical, dental and life insurance companies.  
As a result, if your genetic data shows a predisposition for serious health conditions, you may be 
unable to receive health insurance in the future.  Researchers will then use this data in 
conjunction with the self-report questionnaire in hopes of determining if there is a genetic link 
between subjective well-being and the P36 Genome.  As benefits, participants will receive $100 
for their genetic contribution, and will gain firsthand knowledge of how genetic research is 
conducted.  Potential risks during the study include a minor swelling reaction to the buccal swab 
and potential psychological discomfort from the presented questionnaires. 
 
Questions or information requests regarding this study should be directed to the experimenters in 
charge of the review study, Zachary Batchelder at zacharyb@iastate.edu or Norman Scott at 
nascott@iastate.edu.  If you have any questions about the rights of research subjects or research-
related injury, please contact the IRB administrator, (515) 294-4566, irb@iastate.edu, or 
Director, (515) 294-3115, Office for Responsible Research, Iowa State University, Ames, Iowa 
50011. 
 
Please answer the following questions regarding this study to the best of your ability: 
 1) How much would you be paid to participate in this study? 
___________________________________________________________________ 
 
 
2) Will your information be shared with people other than the researchers? 
___________________________________________________________________ 
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Please rate your responses to the following questions about this study using the scoring system 
provided: 
1. After reading the description, how willing would you be to participate in this study? 
Not At All Willing              Very Willing 
1  2  3  4  5  6  
2. How likely would students who are similar to you be to participate in this study? 
Not At All Likely              Very Likely 
 1  2  3  4  5  6  
3. How concerned are you regarding the loss of the privacy of your personal information in this 
study? 
Not At All Concerned              Very Concerned 
 1  2  3  4  5  6  
4. How much risk to your privacy do you feel it is to have your DNA sample put in the database 
being used for this study? 
Not At All Risky              Very Risky 
1  2  3  4  5  6  
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APPENDIX T – TEST FOR HOMOGENEITY OF VARIANCES 
 
  Item 
Levene 
Statistic df1 df2 Sig. 
WTP1xLow 1.285 1 161 .259 
WTP2xLow 2.496 1 162 .116 
RiskP1xLow .293 1 162 .589 
RiskP2xLow .358 1 163 .550 
WTP1xHigh 1.116 1 162 .292 
WTP2xHigh 1.943 1 163 .165 
RiskP1xHigh .346 1 163 .557 
RiskP2xHigh .847 1 163 .359 
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APPENDIX U – TEST FOR NORMALITY 
 
Group 
  
Group 
   
Statistic df Sig. 
 
Statistic df Sig. 
WTP1: 
How willing 
would you 
be to 
participate? 
(Low Risk) 
$0 
Condition 
.903 77 .001 
 
RiskPerc1: 
How 
concerned 
are you 
regarding 
the loss of 
the privacy 
of your 
personal 
information? 
(Low Risk) 
$0 
Condition 
.875 77 .001 
$100 
Condition 
.898 83 .001 
 
$100 
Condition 
.914 83 .001 
WTP2: 
How likely 
would 
students 
who are 
similar to 
you be to 
participate? 
(Low Risk) 
$0 
Condition 
.923 77 .001 
 
RiskPerc2: 
How risky is 
it to have 
your DNA 
sample put 
in the 
database? 
(Low Risk) 
$0 
Condition 
.863 77 .001 
$100 
Condition 
.906 83 .001 
 
$100 
Condition 
.917 83 .001 
WTP1: 
How willing 
would you 
be to 
participate? 
(High Risk) 
$0 
Condition 
.861 77 .001 
 
RiskPerc1: 
How 
concerned 
are you 
regarding 
the loss of 
the privacy 
of your 
personal 
information? 
(High Risk) 
$0 
Condition 
.858 77 .001 
$100 
Condition 
.908 83 .001 
 
$100 
Condition 
.885 83 .001 
WTP2: 
How likely 
would 
students 
who are 
similar to 
you be to 
participate? 
(High Risk) 
$0 
Condition 
.889 77 .001 
 
RiskPerc2: 
How risky is 
it to have 
your DNA 
sample put 
in the 
database? 
(High Risk) 
$0 
Condition 
.892 77 .001 
$100 
Condition 
.924 83 .001 
 
$100 
Condition 
.903 83 .001 
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APPENDIX V – CORRELATIONS OF DEPENDENT VARIABLES 
 
WTP1     
(Low 
Risk) 
WTP2     
(Low 
Risk) 
RiskPerc1 
(Low 
Risk) 
RiskPerc2 
(Low 
Risk) 
WTP1    
(High 
Risk) 
WTP2    
(High 
Risk) 
RiskPerc1 
(High 
Risk) 
RiskPerc2  
(High 
Risk) 
WTP1     
(Low 
Risk) 
        
WTP2     
(Low 
Risk) 
.814** 
       
RiskPerc1 
(Low 
Risk) 
-.364** -.226** 
      
RiskPerc2 
(Low 
Risk) 
-.334** -.229** .774** 
     
WTP1    
(High 
Risk) 
.212** .268** .087 .028 
    
WTP2    
(High 
Risk) 
.127 .285** .144 .111 .900** 
   
RiskPerc1 
(High 
Risk) 
-.009 -.005 .279** .247** -.643** -.569** 
  
RiskPerc2  
(High 
Risk) 
-.018 -.017 .165* .278** -.655** -.609** .779** 
 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
*. Correlation is significant at the 0.05 level (2-tailed). 
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APPENDIX W – DEPENDENT VARIABLE AND NEO CORRELATIONS 
Item     NEOOpen NEOCons NEOExtrav NEOAgre NEONeur 
WTP1: How willing would 
you be to participate? (Low 
Risk) 
 Pearson 
Correlation 
.039 -.034 .025 .097 -.152 
 Sig. .633 .679 .757 .250 .066 
WTP2: How likely would 
students who are similar to 
you be to participate? (Low 
Risk) 
 Pearson 
Correlation 
.108 -.003 .043 .096 -.085 
 Sig. .191 .974 .599 .255 .309 
RiskPerc1: How concerned 
are you regarding the loss of 
the privacy of your personal 
information? (Low Risk) 
 Pearson 
Correlation 
-.004 .140 .161* .101 .175* 
 Sig.  .966 .085 .046 .229 .033 
RiskPerc2: How risky is it 
to have your DNA sample 
put in the database? (Low 
Risk) 
 Pearson 
Correlation 
.021 .092 .135 .071 .103 
 Sig.  .794 .259 .096 .396 .211 
WTP1: How willing would 
you be to participate? (High 
Risk) 
 Pearson 
Correlation 
.219** .121 .216** .173* .075 
 Sig .007 .139 .007 .039 .364 
WTP2: How likely would 
students who are similar to 
you be to participate? (High 
Risk) 
 Pearson 
Correlation 
.179* .161* .199* .179* .090 
 Sig.  .029 .047 .013 .032 .277 
RiskPerc1: How concerned 
are you regarding the loss of 
the privacy of your personal 
information? (High Risk) 
 Pearson 
Correlation 
-.100 -.005 -.029 -.020 .048 
 Sig.  .223 .951 .718 .814 .561 
RiskPerc2: How risky is it 
to have your DNA sample 
put in the database? (High 
Risk) 
 Pearson 
Correlation 
-.104 -.031 -.088 -.005 .056 
  Sig. .203 .709 .275 .955 .497 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
